SEC Filing | Genpact Ltd

View:

Download DOC

Download PDF

Download XLS

Download XBRL

g-10q_20200930.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

☒	Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period ended September 30, 2020

☐	Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Transition Period from to

Commission file number: 001-33626

GENPACT LIMITED

(Exact name of registrant as specified in its charter)

Bermuda

98-0533350

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

Victoria Place, 5th Floor

31 Victoria Street

Hamilton HM 10

Bermuda

(441) 294-8000

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive office)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common shares, par value $0.01 per share	G	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐

Non-accelerated filer	☐	Smaller reporting company	☐

Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 4, 2020, there were 189,347,684 common shares, par value $0.01 per share, of the registrant issued and outstanding.

TABLE OF CONTENTS

	Item No.		Page No.

PART I		Financial Information
	1.	Unaudited Consolidated Financial Statements
		Consolidated Balance Sheets as of December 31, 2019 and September 30, 2020	1
		Consolidated Statements of Income for the three and nine months ended September 30, 2019 and 2020	2
		Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2019 and 2020	3
		Consolidated Statements of Equity for the three and nine months ended September 30, 2019 and 2020	4
		Consolidated Statements of Cash Flows for the nine months ended September 30, 2019 and 2020	8
		Notes to the Consolidated Financial Statements	9
	2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	45
	3.	Quantitative and Qualitative Disclosures About Market Risk	64
	4.	Controls and Procedures	64

PART II		Other Information
	1.	Legal Proceedings	65
	1A.	Risk Factors	65
	2.	Unregistered Sales of Equity Securities and Use of Proceeds	65
	6.	Exhibits	66

SIGNATURES			67

PART I - FINANCIAL INFORMATION

Item 1. Unaudited Consolidated Financial Statements

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Balance Sheets

(Unaudited)

(In thousands, except per share data and share count)

	Notes	As of December 31, 2019			As of September 30, 2020
Assets
Current assets
Cash and cash equivalents	4	$	467,096		$	803,399
Accounts receivable, net of reserve for doubtful receivables of $29,969 and allowance for credit losses of $25,552 as of December 31, 2019 and September 30, 2020, respectively	5		914,255			859,070
Prepaid expenses and other current assets	8		170,325			216,244
Total current assets		$	1,551,676		$	1,878,713

Property, plant and equipment, net	9		254,035			237,473
Operating lease right-of-use assets			330,854			331,149
Deferred tax assets	23		89,715			105,160
Intangible assets, net	10		230,861			176,908
Goodwill	10		1,574,466			1,567,603
Contract cost assets	20		205,498			211,794
Other assets, net of reserve for doubtful assets of $0 and allowance for credit losses of $2,566 as of December 31, 2019 and September 30, 2020, respectively			217,079			294,838
Total assets		$	4,454,184		$	4,803,638

Liabilities and equity
Current liabilities
Short-term borrowings	11	$	70,000		$	245,000
Current portion of long-term debt	12		33,509			33,530
Accounts payable			21,981			30,754
Income taxes payable	23		43,186			94,744
Accrued expenses and other current liabilities	13		683,871			677,430
Operating leases liability			57,664			65,192
Total current liabilities		$	910,211		$	1,146,650

Long-term debt, less current portion	12		1,339,796			1,315,477
Operating leases liability			302,100			305,074
Deferred tax liabilities	23		3,990			3,236
Other liabilities	14		208,916			256,021
Total liabilities		$	2,765,013		$	3,026,458

Shareholders' equity
Preferred shares, $0.01 par value, 250,000,000 authorized, none issued			—			—
Common shares, $0.01 par value, 500,000,000 authorized, 190,118,181 and 190,403,947 issued and outstanding as of December 31, 2019 and September 30, 2020, respectively			1,896			1,900
Additional paid-in capital			1,570,575			1,612,084
Retained earnings			648,656			748,621
Accumulated other comprehensive income (loss)			(531,956	)		(585,425	)
Total equity		$	1,689,171		$	1,777,180
Commitments and contingencies	26
Total liabilities and equity		$	4,454,184		$	4,803,638

See accompanying notes to the Consolidated Financial Statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Income

(Unaudited)

(In thousands, except per share data and share count)

		Three months ended September 30,						Nine months ended September 30,
	Notes	2019			2020			2019			2020
Net revenues	20	$	888,799		$	935,523		$	2,579,804		$	2,758,809
Cost of revenue			573,659			605,829			1,664,040			1,804,492
Gross profit		$	315,140		$	329,694		$	915,764		$	954,317
Operating expenses:
Selling, general and administrative expenses			194,537			198,335			582,251			581,989
Amortization of acquired intangible assets	10		6,960			10,235			23,565			31,673
Other operating (income) expense, net	21		59			(3,518	)		90			14,991
Income from operations		$	113,584		$	124,642		$	309,858		$	325,664
Foreign exchange gains (losses), net			6,727			(2,402	)		3,646			11,611
Interest income (expense), net	22		(10,221	)		(12,757	)		(33,487	)		(38,072	)
Other income (expense), net	25		704			960			5,067			946
Income before equity-method investment activity, net and income tax expense		$	110,794		$	110,443		$	285,084		$	300,149
Equity-method investment activity, net			(5	)		—			(16	)		—
Income before income tax expense		$	110,789		$	110,443		$	285,068		$	300,149
Income tax expense	23		22,669			25,008			62,385			66,855
Net income		$	88,120		$	85,435		$	222,683		$	233,294
Earnings per common share	18
Basic		$	0.46		$	0.45		$	1.17		$	1.22
Diluted		$	0.45		$	0.43		$	1.14		$	1.19
Weighted average number of common shares used in computing earnings per common share	18
Basic			190,599,049			190,949,108			190,071,418			190,705,671
Diluted			195,890,841			196,655,140			194,683,699			196,100,067

See accompanying notes to the Consolidated Financial Statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)

(In thousands)

	Three months ended September 30,						Nine months ended September 30,
	2019			2020		2019				2020
Net income (loss)	$	88,120		$	85,435	$		222,683		$	233,294
Other comprehensive income:
Currency translation adjustments		(39,404	)		36,106			(24,677	)		(36,959	)
Net income (loss) on cash flow hedging derivatives, net of taxes (Note 7)		(11,360	)		19,856			1,683			(18,893	)
Retirement benefits, net of taxes		346			301			773			2,383
Other comprehensive income (loss)		(50,418	)		56,263			(22,221	)		(53,469	)
Comprehensive income (loss)	$	37,702		$	141,698	$		200,462		$	179,825

See accompanying notes to the Consolidated Financial Statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Equity

For the nine months ended September 30, 2019

(Unaudited)

(In thousands, except share count)


	Common shares												Accumulated Other
	No. of Shares			Amount			Additional Paid-in Capital			Retained Earnings			Comprehensive Income (Loss)			Total Equity
Balance as of January 1, 2019		189,346,101		$	1,888		$	1,471,301		$	438,453		$	(507,460	)	$	1,404,182
Issuance of common shares on exercise of options (Note 16)		622,494			6			9,499			—		—				9,505
Issuance of common shares under the employee stock purchase plan (Note 16)		195,221			2			6,442			—			—			6,444
Net settlement on vesting of restricted share units (Note 16)		557,917			6			(3,794	)		—			—			(3,788	)
Stock repurchased and retired (Note17)		(608,285	)		(6	)		—			(23,895	)		—			(23,901	)
Expenses related to stock purchase (Note 17)		—			—			—			(12	)		—			(12	)
Stock-based compensation expense (Note 16)		—			—			61,307			—			—			61,307
Comprehensive income (loss):
Net income (loss)		—			—			—			222,683			—			222,683
Other comprehensive income (loss)		—			—			—			—			(22,221	)		(22,221	)
Dividend ($0.255 per common share, Note 17)		—			—			—			(48,515	)		—			(48,515	)
Balance as of September 30, 2019		190,113,448		$	1,896		$	1,544,755		$	588,714		$	(529,681	)	$	1,605,684

See accompanying notes to the Consolidated Financial Statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Equity

For the three months ended September 30, 2019

(Unaudited)

(In thousands, except share count)

	Common shares
	No. of Shares			Amount			Additional Paid-in Capital			Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Total Equity
Balance as of July 1, 2019		190,486,041		$	1,899		$	1,520,025		$	540,709		$	(479,263	)	$	1,583,370
Issuance of common shares on exercise of options (Note 16)		115,997			1			2,227			—			—			2,228
Issuance of common shares under the employee stock purchase plan (Note 16)		60,875			1			2,243			—			—			2,244
Net settlement on vesting of restricted share units (Note 16)		58,820			1			(1,060	)		—			—			(1,059	)
Stock repurchased and retired (Note17)		(608,285	)		(6	)		—			(23,895	)		—			(23,901	)
Expenses related to stock purchase (Note 17)		—			—			—			(12	)		—			(12	)
Stock-based compensation expense (Note 16)		—			—			21,320			—			—			21,320
Comprehensive income (loss):
Net income (loss)		—			—			—			88,120			—			88,120
Other comprehensive income (loss)		—			—			—			—			(50,418	)		(50,418	)
Dividend ($0.085 per common share, Note 17)		—			—			—			(16,208	)		—		$	(16,208	)
Balance as of September 30, 2019		190,113,448		$	1,896		$	1,544,755		$	588,714		$	(529,681	)	$	1,605,684

See accompanying notes to the Consolidated Financial Statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Equity

For the nine months ended September 30, 2020

(Unaudited)

(In thousands, except share count)


	Common shares
	No. of Shares			Amount			Additional Paid-in Capital			Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Total Equity
Balance as of January 1, 2020		190,118,181		$	1,896		$	1,570,575		$	648,656		$	(531,956	)	$	1,689,171
Transition period adjustment pursuant to ASC 326, net of tax		—			—			—			(3,984	)		—			(3,984	)
Adjusted balance as of January 1, 2020		190,118,181			1,896			1,570,575			644,672			(531,956	)		1,685,187
Issuance of common shares on exercise of options (Note 16)		542,634			6			10,863			—			—			10,869
Issuance of common shares under the employee stock purchase plan (Note 16)		241,953			3			8,389			—			—			8,392
Net settlement on vesting of restricted share units (Note 16)		380,625			4			(7,725	)		—			—			(7,721	)
Net settlement on vesting of performance units (Note 16)		902,532			9			(25,836	)		—			—			(25,827	)
Stock repurchased and retired (Note 17)		(1,781,978	)		(18	)		—			(73,534	)		—			(73,552	)
Expense related to stock purchase (Note 17)		—			—			—			(36	)		—			(36	)
Stock-based compensation expense (Note 16)		—			—			55,818			—			—			55,818
Comprehensive income (loss):
Net income (loss)		—			—			—			233,294			—			233,294
Other comprehensive income (loss)		—			—			—			—			(53,469	)		(53,469	)
Dividend ($0.293 per common share, Note 17)		—			—			—			(55,775	)		—			(55,775	)
Balance as of September 30, 2020		190,403,947		$	1,900		$	1,612,084		$	748,621		$	(585,425	)	$	1,777,180

See accompanying notes to the Consolidated Financial Statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Equity

For the three months ended September 30, 2020

(Unaudited)

(In thousands, except share count)


	Common shares												Accumulated Other
	No. of Shares			Amount			Additional Paid-in Capital			Retained Earnings			Comprehensive Income (Loss)			Total Equity
Balance as of July 1, 2020		190,721,373		$	1,903		$	1,590,017		$	710,382		$	(641,688	)	$	1,660,614
Issuance of common shares on exercise of options (Note 16)		203,306			2			4,271			—			—			4,273
Issuance of common shares under the employee stock purchase plan (Note 16)		67,639			1			2,567			—			—			2,568
Net settlement on vesting of restricted share units (Note 16)		151,419			2			(4,258	)		—			—			(4,256	)
Net settlement on vesting of performance units (Note 16)		—			—			—			—			—			—
Stock repurchased and retired (Note 17)		(739,790	)		(8	)		—			(28,544	)		—			(28,552	)
Expenses related to stock repurchase (Note 17)		—			—			—			(15	)		—			(15	)
Stock-based compensation expense (Note 16)		—			—			19,487			—			—			19,487
Comprehensive income (loss):
Net income (loss)		—			—			—			85,435			—			85,435
Other comprehensive income (loss)		—			—			—			—			56,263			56,263
Dividend ($0.098 per common share, Note 17)		—			—			—			(18,637	)		—			(18,637	)
Balance as of September 30, 2020		190,403,947		$	1,900		$	1,612,084		$	748,621		$	(585,425	)	$	1,777,180

See accompanying notes to the Consolidated Financial Statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

	Nine months ended September 30,
		2019			2020
Operating activities
Net income	$	222,683		$	233,294
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		70,234			88,273
Amortization of debt issuance costs (including loss on extinguishment of debt)		1,288			1,685
Amortization of acquired intangible assets		23,565			31,673
Write-down of intangible assets and property, plant and equipment		3,511			10,647
Reserve for doubtful receivables/allowance for credit losses		7,169			3,226
Unrealized loss (gain) on revaluation of foreign currency asset/liability		(4,862	)		6,164
Stock-based compensation expense		61,307			55,818
Deferred income taxes		(6,946	)		(9,287	)
Write-down of operating lease right-of-use assets and other assets		—			10,244
Others, net		(2,605	)		(1,131	)
Change in operating assets and liabilities:
(Increase) decrease in accounts receivable		(97,269	)		49,299
Increase in prepaid expenses, other current assets, contract cost assets, operating lease right-of-use assets and other assets		(87,064	)		(148,909	)
Decrease in accounts payable		(20,670	)		(2,646	)
Increase in accrued expenses, other current liabilities, operating leases liability and other liabilities		122,411			44,830
Increase in income taxes payable		48,567			52,033
Net cash provided by operating activities	$	341,319		$	425,213
Investing activities
Purchase of property, plant and equipment		(55,071	)		(47,932	)
Payment for internally generated intangible assets (including intangibles under development)		(26,261	)		(8,391	)
Proceeds from sale of property, plant and equipment		1,621			447
Payment for business acquisitions, net of cash acquired		(6,305	)		—
Net cash used for investing activities	$	(86,016	)	$	(55,876	)
Financing activities
Repayment of finance lease obligations		(6,256	)		(7,240	)
Payment of debt issuance costs		—			(620	)
Repayment of long-term debt		(25,500	)		(25,500	)
Proceeds from short-term borrowings		50,000			455,000
Repayment of short-term borrowings		(100,000	)		(280,000	)
Proceeds from issuance of common shares under stock-based compensation plans		15,949			19,261
Payment for net settlement of stock-based awards		(3,177	)		(33,157	)
Payment of earn-out consideration		(12,790	)		—
Dividend paid		(48,515	)		(55,775	)
Payment for stock repurchased and retired (including expenses related to stock repurchase)		(23,913	)		(73,588	)
Net cash used for financing activities	$	(154,202	)	$	(1,619	)
Effect of exchange rate changes		(12,625	)		(31,415	)
Net increase in cash and cash equivalents		101,101			367,718
Cash and cash equivalents at the beginning of the period		368,396			467,096
Cash and cash equivalents at the end of the period	$	456,872		$	803,399
Supplementary information
Cash paid during the period for interest	$	31,633		$	28,160
Cash paid during the period for income taxes, net of refund	$	65,562		$	131,456

See accompanying notes to the Consolidated Financial Statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

1. Organization

The Company is a global professional services firm that drives digitally-led innovation and runs digitally-enabled intelligent operations for its clients, guided by its experience running thousands of processes for hundreds of Fortune Global 500 clients. The Company has more than 96,300 employees serving clients in key industry verticals from more than 30 countries.

2. Summary of significant accounting policies

(a) Basis of preparation and principles of consolidation

The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) and the rules and regulations of the Securities and Exchange Commission (the “SEC”) for reporting on Form 10-Q. Accordingly, they do not include certain information and note disclosures required by generally accepted accounting principles for annual financial reporting and should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. The accompanying consolidated financial statements reflect all adjustments that management considers necessary for a fair presentation of the results of operations for these periods.

The accompanying financial statements have been prepared on a consolidated basis and reflect the financial statements of Genpact Limited, a Bermuda company, and all of its subsidiaries that are more than 50% owned and controlled. When the Company does not have a controlling interest in an entity but exerts significant influence over the entity, the Company applies the equity method of accounting. All intercompany transactions and balances are eliminated in consolidation.

(b) Use of estimates

The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements. Significant items subject to such estimates and assumptions include the useful lives of property, plant and equipment, intangible assets and goodwill, revenue recognition, allowance for credit losses, valuation allowances for deferred tax assets, the valuation of derivative financial instruments, the measurement of lease liabilities and right-of-use (“ROU”) assets, measurements of stock-based compensation, assets and obligations related to employee benefits, the nature and timing of the satisfaction of performance obligations, the standalone selling price of performance obligations, variable consideration, other obligations for revenue recognition, income tax uncertainties and other contingencies. Management believes that the estimates used in the preparation of the consolidated financial statements are reasonable, and management has made assumptions about the possible effects of the novel coronavirus (“COVID-19”) pandemic on critical and significant accounting estimates. Although these estimates and assumptions are based upon management’s best knowledge of current events and actions, actual results could differ from these estimates. Any changes in estimates are adjusted prospectively in the Company’s consolidated financial statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

2. Summary of significant accounting policies (Continued)

The Company accounts for its business combinations using the acquisition method of accounting in accordance with Accounting Standard Codification (“ASC”) Topic 805, Business Combinations, by recognizing the identifiable tangible and intangible assets acquired and liabilities assumed, and any non-controlling interest in the acquired business, measured at their acquisition date fair values. Contingent consideration is included within the acquisition cost and is recognized at its fair value on the acquisition date. A liability resulting from contingent consideration is re-measured to fair value as of each reporting date until the contingency is resolved. Changes in fair value are recognized in earnings. All assets and liabilities of the acquired businesses, including goodwill, are assigned to reporting units. Acquisition-related costs are expensed as incurred under selling, general and administrative expenses.

Goodwill represents the cost of acquired businesses in excess of the fair value of identifiable tangible and intangible net assets purchased. Goodwill is not amortized but is tested for impairment at least on an annual basis on December 31, based on a number of factors, including operating results, business plans and future cash flows. The Company performs an assessment of qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Based on the assessment of events or circumstances, the Company performs a quantitative assessment of goodwill impairment if it determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, based on the quantitative impairment analysis, the carrying value of the goodwill of a reporting unit exceeds the fair value of such goodwill, an impairment loss is recognized in an amount equal to the excess. In addition, the Company performs a qualitative assessment of goodwill impairment between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. See Note 10 for information and related disclosures.

Intangible assets acquired individually or with a group of other assets or in a business combination and developed internally are carried at cost less accumulated amortization and accumulated impairment loss based on their estimated useful lives as follows:

Customer-related intangible assets		1-11 years
Marketing-related intangible assets		2-10 years
Technology-related intangible assets		2-8 years

Intangible assets are amortized over their estimated useful lives using a method of amortization that reflects the pattern in which the economic benefits of the intangible assets are consumed or otherwise realized.

In business combinations where the fair value of identifiable tangible and intangible net assets purchased exceeds the cost of the acquired business, the Company recognizes the resulting gain under “Other operating (income) expense, net” in the consolidated statements of income.

The Company also capitalizes certain software and technology-related development costs incurred in connection with developing or obtaining software or technology for sale/lease to customers when the initial design phase is completed and commercial and technological feasibility has been established. Any development cost incurred before technological feasibility is established is expensed as incurred as research and development costs. Technological feasibility is established upon completion of a detailed design program or, in its absence, completion of a working model. Capitalized software and technology costs include only (i) external direct costs of materials and services utilized in developing or obtaining software and technology and (ii) compensation and related benefits for employees who are directly associated with the project.

Costs incurred in connection with developing or obtaining software or technology for sale/lease to customers which are under development and not put to use are disclosed under “intangible assets under development.” Advances paid towards the acquisition of intangible assets outstanding as of each balance sheet date are disclosed under “intangible assets under development.”

Capitalized software and technology costs are included in intangible assets under technology-related intangible assets on the Company’s balance sheet and are amortized on a straight-line basis when placed into service over the estimated useful lives of the software and technology.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

2. Summary of significant accounting policies (Continued)

The Company evaluates the remaining useful life of intangible assets that are being amortized at each reporting period wherever events and circumstances warrant a revision to the remaining period of amortization, and the remaining carrying amount of the intangible asset is amortized prospectively over that revised remaining useful life.

(d) Financial instruments and concentration of credit risk

Financial instruments that potentially subject the Company to concentration of credit risk are reflected principally in cash and cash equivalents, derivative financial instruments and accounts receivable. The Company places its cash and cash equivalents and derivative financial instruments with corporations and banks with high investment grade ratings, limits the amount of credit exposure with any one corporation or bank and conducts ongoing evaluations of the creditworthiness of the corporations and banks with which it does business. To reduce its credit risk on accounts receivable, the Company conducts ongoing credit evaluations of its customers. The General Electric Company (“GE”) accounted for 17% of the Company’s receivables as of December 31, 2019 and September 30, 2020. GE accounted for 14% of the Company’s revenues for each of the three and nine month periods ended September 30, 2019, and 12% and 13% of the Company’s revenues for the three and nine month periods ended September 30 2020, respectively.

(e) Accounts receivable

Accounts receivable are recorded at the invoiced or to be invoiced amount and do not bear interest. Amounts collected on trade accounts receivable are included in net cash provided by operating activities in the consolidated statements of cash flows. The Company maintains an allowance for current expected credit losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses which are adjusted to current market conditions and a reasonable and supportable forecast. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers.

(f) Revenue Recognition

The Company derives its revenue primarily from business process management services, including analytics, consulting and related digital solutions and information technology services, which are provided primarily on a time-and-material, transaction or fixed-price basis. The Company recognizes revenue upon the transfer of control of promised services to its customers in an amount that reflects the consideration the Company expects to receive in exchange for those services. Revenues from services rendered under time-and-materials and transaction-based contracts are recognized as the services are provided. The Company’s fixed-price contracts include contracts for customization of applications, maintenance and support services. Revenues from these contracts are recognized ratably over the term of the agreement. The Company accrues for revenue and unbilled receivables for services rendered between the last billing date and the balance sheet date.

The Company’s contracts with its customers also include incentive payments received for discrete benefits delivered or promised to be delivered to the customer or service level agreements that could result in credits or refunds to the customer. Revenues relating to such arrangements are accounted for as variable consideration when the amount of revenue to be recognized can be estimated to the extent that it is probable that a significant reversal of any incremental revenue will not occur.

The Company records deferred revenue attributable to certain process transition activities where such activities do not represent separate performance obligations. Revenues relating to such transition activities are classified under contract liabilities and subsequently recognized ratably over the period in which the related services are performed. Costs relating to such transition activities are fulfillment costs which are directly related to the contract and result in the generation or enhancement of resources. Such costs are expected to be recoverable under the contract and are therefore classified as contract cost assets and recognized ratably over the estimated expected period of benefit under cost of revenue.

Revenues are reported net of value-added tax, business tax and applicable discounts and allowances. Reimbursements of out-of-pocket expenses received from customers have been included as part of revenues.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

2. Summary of significant accounting policies (Continued)

Revenue for performance obligations that are satisfied over time is recognized in accordance with the methods prescribed for measuring progress. The input (cost expended) method has been used to measure progress towards completion as there is a direct relationship between input and the satisfaction of a performance obligation. Provisions for estimated losses, if any, on uncompleted contracts are recorded in the period in which such losses become probable based on the current contract estimates.

The Company enters into multiple-element revenue arrangements in which a customer may purchase a combination of products or services. The Company determines whether each product or service promised to a customer is capable of being distinct, and is distinct in the context of the contract. If not, the promised products or services are combined and accounted for as a single performance obligation. In the event of a multiple-element revenue arrangement, the Company allocates the arrangement consideration to separately identifiable performance obligations based on their relative stand-alone selling prices.

Certain contracts may include offerings such as sale of licenses, which may be perpetual or subscription-based. Revenue from distinct perpetual licenses is recognized upfront at the point in time when the software is made available to the customer. Revenue from distinct, non-cancellable, subscription-based licenses is recognized at the point in time it is transferred to the customer. Revenue from any associated maintenance or ongoing support services is recognized ratably over the term of the contract. For a combined software license/services performance obligation, revenue is recognized over the period that the services are performed.

All incremental and direct costs incurred for acquiring contracts, such as certain sales commissions, are classified as contract cost assets. Such costs are amortized over the expected period of benefit and recorded under selling, general and administrative expenses.

Other upfront fees paid to customers are classified as contract assets. Such fees are amortized over the expected period of benefit and recorded as an adjustment to the transaction price and deducted from revenue.

Timing of revenue recognition may differ from the timing of invoicing. If a payment is received in respect of services prior to the delivery of services, the payment is recognized as an advance from the customer and classified as a contract liability. Contract assets and contract liabilities relating to the same customer contract are offset against each other and presented on a net basis in the consolidated financial statements.

Significant judgements

The Company often enters into contracts with its customers that include promises to transfer multiple products and services to the customer. Determining whether products and services are considered distinct performance obligations that should be accounted for separately rather than together may require significant judgement.

Judgement is also required to determine the standalone selling price for each distinct performance obligation. In instances where the standalone selling price is not directly observable, it is determined using information that may include market conditions and other observable inputs.

Customer contracts sometimes include incentive payments received for discrete benefits delivered to the customer or service level agreements that could result in credits or refunds to the customer. Such amounts are estimated at contract inception and are adjusted at the end of each reporting period as additional information becomes available only to the extent that it is probable that a significant reversal of any incremental revenue will not occur.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

2. Summary of significant accounting policies (Continued)

(g) Leases

At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The Company’s assessment is based on whether: (1) the contract involves the use of a distinct identified asset, (2) the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the term of the contract, and (3) the Company has the right to direct the use of the asset. At the inception of a lease, the consideration in the contract is allocated to each lease component based on its relative standalone price to determine the lease payments. Leases entered into prior to January 1, 2019 have been accounted for under ASC Topic 840, Lease Classification, and were not reassessed on adoption of ASC Topic 842, Leases, on January 1, 2019.

Leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (1) the lease transfers ownership of the asset by the end of the lease term, (2) the lease contains an option to purchase the asset that is reasonably certain to be exercised, (3) the lease term is for a major part of the remaining useful life of the asset or (4) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset. A lease is classified as an operating lease if it does not meet any one of the above criteria.

For all leases at the lease commencement date, a right-of-use (ROU) asset and a lease liability are recognized. The lease liability represents the present value of the lease payments under the lease. Lease liabilities are initially measured at the present value of the lease payments not yet paid, discounted using the discount rate for the lease at the lease commencement. The lease liabilities are subsequently measured on an amortized cost basis. The lease liability is adjusted to reflect interest on the liability and the lease payments made during the period. Interest on the lease liability is determined as the amount that results in a constant periodic discount rate on the remaining balance of the liability.

The ROU asset represents the right to use the leased asset for the lease term. The ROU asset for each lease initially includes the amount of the initial measurement of the lease liability adjusted for any lease payments made to the lessor at or before the commencement date, accrued lease liabilities and any lease incentives received or any initial direct costs incurred by the Company.

The ROU asset of finance leases is subsequently measured at cost, less accumulated amortization and any accumulated impairment losses. The ROU asset of operating leases is subsequently measured from the carrying amount of the lease liability at the end of each reporting period, and is equal to the carrying amount of lease liabilities adjusted for (1) unamortized initial direct costs, (2) prepaid/(accrued) lease payments and (3) the unamortized balance of lease incentives received.

The Company has elected to not separate lease and non-lease components for all of its leases and to use the recognition exemptions for lease contracts that, at commencement date, have a lease term of 12 months or less and do not contain a purchase option (“short-term leases”).

Significant judgements

The Company determines the lease term as the non-cancellable term of the lease, together with any periods covered by an option to extend the lease if it is reasonably certain to be exercised, or any periods covered by an option to terminate the lease, if it is reasonably certain not to be exercised.

Under certain of its leases, the Company has a renewal and termination option to lease assets for additional terms between one and fifteen years. The Company applies judgement in evaluating whether it is reasonably certain to exercise the option to renew or terminate the lease. The Company considers all relevant factors that create an economic incentive for it to exercise the renewal or termination option. After the commencement date, the Company reassesses the lease term if there is a significant event or change in circumstances that is within the Company’s control and affects its ability to exercise (or not to exercise) the option to renew or terminate.

The Company has applied an incremental borrowing rate for the purpose of computing lease liabilities based on the remaining lease term and the rates prevailing in the jurisdictions where leases were executed.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

2. Summary of significant accounting policies (Continued)

For the nine months ended September 30, 2020, due to the impact of the COVID-19 pandemic on the Company’s current and future revenues and operations, the Company recorded restructuring charges related to the abandonment of leased office premises and related assets. See note 27 for additional information.

(h) Cost of revenue

Cost of revenue primarily consists of salaries and benefits (including stock-based compensation), recruitment, training and related costs of employees who are directly responsible for the performance of services for clients, their supervisors and certain support personnel who may be dedicated to a particular client or a set of processes. It also includes operational expenses, which consist of facilities maintenance expenses, travel and living expenses, rent, IT expenses, and consulting and certain other expenses. Consulting charges represent the cost of consultants and contract resources with specialized skills who are directly responsible for the performance of services for clients and travel and other billable costs related to the Company’s clients. It also includes depreciation of property, plant and equipment, and amortization of intangible and ROU assets which are directly related to providing services that generate revenue.

(i) Selling, general and administrative expenses

Selling, general and administrative (SG&A) expenses consist of expenses relating to salaries and benefits (including stock-based compensation) as well as costs related to recruitment, training and retention of senior management and other support personnel in enabling functions such as human resources, finance, legal, marketing, sales and sales support, and other support personnel. The operational costs component of SG&A expenses also includes travel and living costs for such personnel. SG&A expenses also include acquisition-related costs, legal and professional fees (which represent the costs of third party legal, tax, accounting and other advisors), investment in research and development, digital technology, advanced automation and robotics, and an allowance for credit losses. It also includes depreciation of property, plant and equipment, and amortization of intangibles and ROU assets other than those included in cost of revenue.

(j) Changes in accounting policies

Except as described below, the Company has applied accounting policies consistently to all periods presented in these consolidated financial statements. The Company adopted ASC Topic 326, Financial Instruments—Credit Losses (“Topic 326”), effective January 1, 2020. As a result of the Company’s adoption of this new standard, current expected credit losses (“CECL”) are measured using lifetime “expected credit loss” methodology, replacing the incurred loss model that recognized losses only when they became probable and estimable. The Company changed its accounting policy for recognition and measurement of CECL as detailed below. Topic 326 is applicable to financial assets measured at amortized cost, such as accounts receivable (including deferred billings), deposits, employee advances and cash and cash equivalents. It requires historical loss data to be adjusted to reflect changes in asset-specific considerations, current conditions and reasonable and supportable forecasts of future economic conditions. In order to analyze credit losses on financial assets, the Company applied a combination of methods, including the discounted cash flow and roll-rate methods, to determine expected credit losses. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. The Company applied Topic 326 using the modified retrospective transition approach, which involves recognizing the cumulative effect of initial adoption of Topic 326 as an adjustment to its opening retained earnings as of January 1, 2020. Therefore, comparative information prior to the adoption date has not been adjusted.

As a result of adoption of ASC 326, the Company recognized an incremental allowance for credit losses on its accounts receivable and deferred billings of $4,185 and $734, respectively, resulting in an increase in deferred tax assets of $935 with a corresponding decrease in retained earnings of $3,984, net of deferred tax.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

2. Summary of significant accounting policies (Continued)

Credit losses (effective January 1, 2020)

The Company recognizes an allowance for credit losses for all debt instruments other than those held at fair value through profit or loss. The Company pools its accounts receivable based on similar risk characteristics in estimating expected credit losses. Credit losses for accounts receivable are based on the roll-rate method, and the Company recognizes a loss allowance based on lifetime expected credit losses at each reporting date. The Company has established a provision matrix based on historical credit loss experience, adjusted for forward-looking factors and the economic environment. The Company believes the most relevant forward-looking factors are economic environment, gross domestic product, inflation rates and unemployment rates for each of the countries in which the Company or its customers operate, and accordingly the Company adjusts historical loss rates based on expected changes in these factors. At every reporting date, observed historical default rates are updated to reflect changes in the Company’s forward-looking estimates.

Credit losses for other financial assets including deferred billings are based on the discounted cash flow (“DCF”) method. Under the DCF method, the allowance for credit losses reflects the difference between the contractual cash flows due in accordance with the contract and the present value of the cash flows expected to be collected. The expected cash flows are discounted at the effective interest rate of the financial asset. Such allowances are based on the credit losses expected to arise over the life of the asset which includes consideration of prepayments based on the Company’s expectation as of the balance sheet date.

A financial asset is written off when it is deemed uncollectable and there is no reasonable expectation of recovering the contractual cash flows. Expected recoveries of amounts previously written off, not to exceed the aggregate amounts previously written off, are included in determining the allowance at each reporting period.

Credit losses are presented as a credit loss expense within “Selling, general and administrative expenses.” Subsequent recoveries of amounts previously written off are credited against the same line item.

Impact on consolidated financial statements

The following table summarizes the impact of the Company’s adoption of Topic 326 on its consolidated financial statements as of January 1, 2020.

	As reported December 31, 2019		Adoption of Topic 326 Increase/(Decrease)			Balance as of January 1, 2020
Accounts receivable, net		914,255		(4,185	)		910,070
Other assets		217,079	(734)*				216,345
Deferred tax assets		89,715		935			90,650
Retained earnings		648,656		(3,984	)		644,672

*Represents the expected credit loss on deferred billings amounting to $7,858 included in “Other assets.”

(k) Recently issued accounting pronouncements

The authoritative bodies release standards and guidance which are assessed by management for impact on the Company’s consolidated financial statements.

The Company has adopted the following recently released accounting standards:

The Company adopted ASC Topic 842, Leases, with a date of initial application of January 1, 2019, using the modified retrospective approach. The significant accounting policy for leases is outlined in section (g) above.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

2. Summary of significant accounting policies (Continued)

In March 2019, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standard Update (“ASU”) 2019-01, Leases (Topic 842): Codification Improvement. The new standard contains several amendments to clarify the codification more generally and/or to correct unintended applications of the guidance. The changes in the new standard eliminate the requirement for transition disclosures related to Topic 250-10-50-3. The guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those years. Early application is permitted. In the quarter ended March 31, 2019, the Company adopted ASU 2019-01 effective January 1, 2019 and no prior periods have been adjusted.

In August 2017, the FASB issued ASU 2017-12, “Derivatives and Hedging.” The amendment expands an entity’s ability to apply hedge accounting to non-financial and financial risk components and requires changes in the fair value of hedging instruments to be presented in the same income statement line as a hedged item. The ASU also amends the presentation and disclosure requirements for the effect of hedge accounting. The ASU must be adopted using a modified retrospective approach with a cumulative effect adjustment recorded to the opening balance of retained earnings as of the initial application date. The ASU was effective for the Company beginning January 1, 2019, including interim periods in the fiscal year 2019. On January 1, 2019, the Company adopted this ASU and concluded that it does not have any impact on its consolidated results of operations, cash flows, financial position and or disclosures.

In July 2019, the FASB issued ASU 2019-07, Codification Updates to SEC Sections. This ASU amends various SEC paragraphs pursuant to the issuance of SEC Final Rule Releases No. 33-10532, Disclosure Update and Simplification, and Nos. 33-10231 and 33-10442, Investment Company Reporting Modernization. The S-X Rule 3-04 requires the presentation of changes in stockholders’ equity in the form of a reconciliation of the beginning balance to the ending balance for each period for which a statement of income is required to be filed with all significant reconciling items. The Company presented changes in stockholders' equity as separate financial statements for the current and comparative year-to-date interim periods beginning on January 1, 2019. This guidance was effective immediately upon issuance. The additional elements of the ASU did not have a material impact on the Company's consolidated results of operations, cash flows, financial position and/or disclosures.

In June 2016, the FASB issued ASU No. 2016-13, “Measurement of credit losses on financial instruments.” The ASU requires measurement and recognition of expected credit losses for financial assets held by the Company. The ASU requires entities to estimate an expected lifetime credit loss on financial assets ranging from short-term trade accounts receivable to long-term financings. The ASU became effective for the Company beginning January 1, 2020, including interim periods in fiscal year 2020.

In May 2019, the FASB issued ASU No. 2019-05, “Financial Instruments—Credit Losses (Topic 326).” The ASU provides final guidance that allows entities to make an irrevocable one-time election upon adoption of the new credit losses standard to measure financial assets at amortized cost (except held-to-maturity securities) using the fair value option. The ASU is effective for the Company beginning January 1, 2020, including interim periods in fiscal year 2020.

In November 2019, the FASB issued ASU No. 2019-11, “Codification Improvements to Topic 326, Financial Instruments—Credit Losses.” This ASU clarifies that the scope of the guidance related to expected recoveries extends to purchased financial assets with credit deterioration. For entities that have not yet adopted ASU 2016-13, the amendments in ASU 2019-11 are effective on the same date as those in ASU 2016-13. For entities that have adopted ASU 2016-13, the amendments in ASU 2019-11 are effective for fiscal years beginning January 1, 2020 and interim periods therein.

The Company adopted ASU 2016-13, ASU 2019-05 and ASU 2019-11 beginning January 1, 2020, including interim periods in fiscal year 2020. The cumulative impact of the adoption of these standards has been described in section (j) above.

In August 2018, the FASB issued ASU No. 2018-13, “Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement.” The ASU modifies the disclosure requirements with respect to fair value measurements. The ASU is effective for the Company beginning January 1, 2020, including interim periods in fiscal year 2020. The Company assessed the impact of this ASU and concluded that it does not have any material impact on its consolidated results of operations, cash flows, financial position or disclosures.

In August 2018, the FASB issued ASU No. 2018-15, “Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract.” The ASU modifies the capitalization requirements with respect to implementation costs incurred by the customer in a hosting arrangement that is a service contract. The ASU is effective for the Company beginning January 1, 2020. The Company assessed the impact of this ASU and concluded that it does not have any material impact on its consolidated results of operations, cash flows, financial position or disclosures.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

2. Summary of significant accounting policies (Continued)

In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments.” The ASU provides additional guidance on the recognition of credit losses and addresses partial-term fair value hedges, fair value hedge basis adjustments and certain transition requirements, among other things. The ASU also addresses the scope of the guidance on the requirement for re-measurement under ASC 820 when using the measurement alternative, certain disclosure requirements and which foreign currency-denominated equity securities must be re-measured at historical exchange rates. The ASU is effective for the Company beginning January 1, 2020, including interim periods in fiscal year 2020. The Company assessed the impact of this ASU and concluded that it does not have any material impact on its consolidated results of operations, cash flows, financial position or disclosures.

In November 2019, the FASB issued ASU No. 2019-08, “Codification Improvements—Share-Based Consideration Payable to a Customer.” The ASU clarifies that share-based consideration payable to a customer is measured in accordance with guidance under AC 718--Share based payments. The ASU is effective for the Company beginning January 1, 2020, including interim periods in fiscal year 2020. The Company assessed the impact of this ASU and concluded that it does not have any material impact on its consolidated results of operations, cash flows, financial position or disclosures.

In March 2020, the FASB issued ASU No. 2020-03, “Codification Improvements to Financial Instruments.” This ASU includes amendments that make the Codification easier to understand and apply by eliminating inconsistencies and providing clarifications in relation to financial instruments. This guidance was effective immediately upon issuance. The additional elements of the ASU did not have a material impact on the Company's consolidated results of operations, cash flows, financial position and or disclosures.

The following recently released accounting standards have not yet been adopted by the Company:

In August 2018, the FASB issued ASU No. 2018-14, “Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans.” The ASU modifies the disclosure requirements with respect to defined benefit pension plans. The ASU is effective for the Company beginning January 1, 2021. Early adoption is permitted. The Company is in the process of assessing the impact of this ASU on its consolidated results of operations, cash flows, financial position and disclosures.

In December 2019, the FASB issued ASU No. 2019-12, “Simplifying the Accounting for Income Taxes”. This ASU removes certain exceptions for investments, intra-period tax allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. The ASU is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning January 1, 2021. Early adoption is permitted. The Company is in the process of assessing the impact of this ASU on its consolidated results of operations, cash flows, financial position or disclosures.

In March 2020, the FASB issued ASU No. 2020-04, “Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” This ASU provides temporary optional expedients and exceptions to the guidance in US GAAP on contract modifications and hedge accounting to ease the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate (“SOFR”). Entities can elect not to apply certain modification accounting requirements to contracts affected by what the guidance calls reference rate reform, if certain criteria are met. An entity that makes this election would not have to remeasure the contracts at the modification date or reassess a previous accounting determination. The guidance is effective upon issuance and generally can be applied through 31 December 2022. The Company is currently evaluating the impact of adopting this guidance.

In August 2020, the FASB issued ASU No. 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”. This ASU eliminates two of the three models in ASC 470-20 that require separating embedded conversion features from convertible instruments. As a result, only conversion features accounted for under the substantial premium model in ASC 470-20 and those that require bifurcation in accordance with ASC 815-15 will be accounted for separately. For contracts in an entity’s own equity, the new guidance eliminates some of the requirements in ASC 815-40 for equity classification. The ASU is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning January 1, 2022. Early adoption is permitted. The Company is in the process of assessing the impact of this ASU on its consolidated results of operations, cash flows, financial position and disclosures.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

2. Summary of significant accounting policies (Continued)

(l) Reclassification

Certain reclassifications have been made in the consolidated financial statements of prior periods to conform to the classification used in the current period. The impact of such reclassifications on the consolidated financial statements is not material.

3. Business acquisitions

(a) Rightpoint Consulting, LLC

On November 12, 2019, the Company acquired 100% of the outstanding equity/limited liability company interests in Rightpoint Consulting, LLC, an Illinois limited liability company, and certain affiliated entities in the United States and India (collectively referred to as “Rightpoint”) for total purchase consideration of $270,669. This amount includes cash consideration of $268,170, net of cash acquired of $2,499. The total purchase consideration paid by the Company to the sellers was $248,470 resulting in a payable of $18,162 which is outstanding as of September 30, 2020. The Company is evaluating adjustments related to certain income and other taxes, which, when determined, may result in the recognition of additional assets or liabilities as of the acquisition date. The measurement period will not exceed one year from the acquisition date. This acquisition is expected to expand the Company’s capabilities in improving customer experience.

The securities purchase agreement between the Company and the selling equity holders of Rightpoint provided certain of the selling equity holders the option to elect to either (a) receive 100% consideration in cash at the closing date for their limited liability company interests and vested options or (b) “roll over” and retain 25% of their Rightpoint limited liability company interests and vested options for a three-year rollover period and receive cash consideration at closing for the remaining 75% of their Rightpoint limited liability company interests and vested options. Certain selling equity holders elected to receive deferred, variable earn-out consideration with an estimated value of $21,500 over the rollover period of three years. The amount of deferred earn-out consideration ultimately payable by the Company to the selling equity holders of Rightpoint will be based on the future revenue multiple of the acquired business and is included in the purchase consideration outstanding as of September 30, 2020. Additionally, under the purchase agreement the selling equity holders are obligated to sell their rollover interests to the Company. Accordingly, the Company has obtained control over 100% of the outstanding equity/limited liability company interests of Rightpoint as of November 12, 2019.

In connection with this acquisition, the Company recorded $46,000 in customer-related intangibles and $29,000 in marketing-related intangibles which have a weighted average amortization period of five years. Goodwill arising from the acquisition amounting to $182,834 has been allocated using a relative fair value allocation method to each of the Company’s reporting segments as follows: to the Banking, Capital Market and Insurance (“BCMI”) segment in the amount of $17,525, to the Consumer Goods, Retail, Life Sciences and Healthcare (“CGRLH”) segment in the amount of $44,365 and to the High Tech, Manufacturing and Services (“HMS”) segment in the amount of $120,944. Of the total goodwill arising from this acquisition, $97,833 is deductible for income tax purposes. The goodwill represents primarily the acquired capabilities, operating synergies and other benefits expected to result from combining the acquired operations with those of the Company.

Acquisition-related costs of $7,385 have been included in selling, general and administrative expenses as incurred. In connection with the transaction, the Company also acquired certain assets with a value of $39,140, assumed certain liabilities amounting to $23,095 and recognized a net deferred tax liability of $3,210. The results of operations of the acquired business and the fair value of the acquired assets and assumed liabilities are included in the Company’s consolidated financial statements with effect from the date of the acquisition.

(b) riskCanvas Holdings, LLC

On January 7, 2019, the Company acquired 100% of the outstanding equity interests in riskCanvas Holdings, LLC, a Delaware limited liability company, for total purchase consideration of $5,747. This amount includes cash consideration of $5,700, net of adjustment for working capital. No portion of the total consideration, payable in cash, was unpaid as of September 30, 2020. This acquisition expands the Company’s services in the areas of financial institution fraud, anti-money laundering and financial transaction surveillance and enhances its consulting capabilities for clients in the financial services industry.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

3. Business acquisitions (Continued)

In connection with this acquisition, the Company recorded $1,700 in customer-related intangibles, $1,400 in software-related intangibles and $100 in restrictive covenants. Goodwill arising from the acquisition amounting to $2,547, which has been allocated to the Company’s BCMI reporting segment and is deductible for income tax purposes. The goodwill primarily represents primarily the acquired capabilities, operating synergies and other benefits expected to result from combining the acquired operations with those of the Company.

Acquisition-related costs of $967 have been included in selling, general and administrative expenses as incurred. In connection with the transaction, the Company also acquired certain assets with a value of $660 and assumed certain liabilities amounting to $707. The results of operations of the acquired business and the fair value of the acquired assets and assumed liabilities are included in the Company’s consolidated financial statements with effect from the date of the acquisition.

4. Cash and cash equivalents

	As of December 31,		As of September 30,
	2019		2020
Cash and other bank balances		467,096		803,399
Total	$	467,096	$	803,399

5. Accounts receivable, net of allowance for credit losses

Accounts receivable were $944,224 and $884,622, reserve for doubtful receivables was $29,969 and allowance for credit losses was $25,552, resulting in net accounts receivable balances of $914,255 and $859,07o as of December 31, 2019 and September 30, 2020, respectively.

The following table provides details of the Company’s allowance for credit losses:


	Year ended December 31, 2019			Nine months ended September 30, 2020
Opening balance as of January 1	$	23,960		$	29,969
Transition period adjustment on accounts receivables (through retained earnings) pursuant to adoption of ASC 326		—			4,185
Adjusted balance as of January 1	$	23,960		$	34,154
Additions due to acquisitions		1,004			—
Additions charged/reversal released to cost and expense	$	7,443		$	1,394
Deductions/effect of exchange rate fluctuations		(2,438	)		(9,996	)
Closing balance	$	29,969		$	25,552

In addition, deferred billings were $7,858 and $23,755, reserve for doubtful assets was $0 and allowance for credit losses was $2,566, resulting in net deferred billings balances of $7,858 and $21,189 as of December 31, 2019 and September 30, 2020, respectively. Total credit losses of $2,566 as of September 30, 2020 includes $734 as a transition date adjustment through retained earnings pursuant to the adoption of ASC 326 and $1,832 as a current period charge. Deferred billings, net of related allowance for credit losses, are included under “other assets” in the consolidated balance sheet.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

6. Fair value measurements

The Company measures certain financial assets and liabilities, including derivative instruments, at fair value on a recurring basis. The fair value measurements of these financial assets and liabilities were determined using the following inputs as of December 31, 2019 and September 30, 2020:

	As of December 31, 2019
	Fair Value Measurements at Reporting Date Using
				Quoted Prices in Active Markets for Identical Assets			Significant Other Observable Inputs			Significant Other Unobservable Inputs
	Total		(Level 1)			(Level 2)			(Level 3)
Assets
Derivative instruments (Note a, c)	$	21,309		$	—		$	21,309		$	—
Deferred compensation plan assets (a, e)		11,208			—			—			11,208
Total	$	32,517		$	—		$	21,309		$	11,208
Liabilities
Earn-out consideration (Note b, d)	$	22,184		$	—		$	—		$	22,184
Derivative instruments (Note b, c)		24,239			—			24,239			—
Deferred compensation plan liability (b, f)		10,943			—			—			10,943
Total	$	57,366		$	—		$	24,239		$	33,127

	As of September 30, 2020
	Fair Value Measurements at Reporting Date Using
				Quoted Prices in Active Markets for Identical Assets			Significant Other Observable Inputs		Significant Other Unobservable Inputs
	Total		(Level 1)			(Level 2)				(Level 3)
Assets
Derivative instruments (Note a, c)	$	20,687		$	—		$	20,687	$		—
Deferred compensation plan assets (Note a, e)		23,680			—			—			23,680
Total	$	44,367		$	—		$	20,687	$		23,680
Liabilities
Earn out consideration (Note b, d)	$	18,162		$	—		$	—	$		18,162
Derivative instruments (Note b, c)		45,790			—			45,790			—
Deferred compensation plan liability (Note b, f)		23,252			—			—			23,252
Total	$	87,204		$	—		$	45,790	$		41,414

(a)	Included in “prepaid expenses and other current assets” and “other assets” in the consolidated balance sheets.

(b)	Included in “accrued expenses and other current liabilities” and “other liabilities” in the consolidated balance sheets.

(c)	The Company values its derivative instruments based on market observable inputs, including both forward and spot prices for the relevant currencies and interest rate indices for relevant interest rates. The quotes are taken from an independent market database.

(d)

The fair value of earn-out consideration, calculated as the present value of expected future payments to be made to the sellers of acquired businesses, was derived by estimating the future financial performance of the acquired businesses using the earn-out formula and performance targets specified in each purchase agreement and adjusting the result to reflect the Company’s estimate of the likelihood of achievement of such targets. Given the significance of the unobservable inputs, the valuations are classified in level 3 of the fair value hierarchy.

(e)

Deferred compensation plan assets consist of life insurance policies held under a Rabbi Trust. Assets held in the Rabbi Trust are valued based on the cash surrender value of the insurance contract, which is determined based on the fair value of the underlying assets included in the insurance portfolio and are therefore classified within level 3 of the fair value hierarchy.

(f)	The fair value of the deferred compensation plan liability is derived based on the fair value of the underlying assets in the insurance policies and is therefore classified within level 3 of the fair value hierarchy.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

6. Fair value measurements (Continued)

The following table provides a roll-forward of the fair value of earn-out consideration categorized as level 3 in the fair value hierarchy for the three and nine months ended September 30, 2019 and 2020:

	Three months ended						Nine months ended
	September 30,						September 30,
	2019			2020			2019			2020
Opening balance	$	3,463		$	21,935		$	17,073		$	22,184
Payments made on earn-out consideration (Note a)		(3,000	)		—			(17,098	)		—
Change in fair value of earn out consideration (Note b)		—			(3,773	)		—			(4,452	)
Others (Note c)		14			—			502			430
Closing balance	$	477		$	18,162		$	477		$	18,162

(a)

Includes an interest payment on earn-out consideration in excess of the acquisition date fair value, which is included in “cash flows from operating activities” amounting to $680 and $0 for the three months ended September 30, 2019 and 2020, respectively, and $4,308 and $0 for the nine months ended September 30, 2019 and 2020, respectively.

(b)	Changes in the fair value of earn-out consideration are reported in “other operating (income) expense, net” in the consolidated statements of income.

(c)

“Others” is comprised of interest expense included in “interest income (expense), net” and the impact of changes in foreign exchange reported in “foreign exchange gains (losses), net” in the consolidated statements of income. This also includes a cumulative translation adjustment reported as a component of “other comprehensive income (loss).”

The following table provides a roll-forward of the fair value of deferred compensation plan assets categorized as level 3 in the fair value hierarchy for the three and nine months ended September 30, 2019 and 2020:

	Three months ended September 30,				Nine months ended September 30,
	2019		2020		2019		2020
Opening balance	$	9,141	$	21,837	$	1,613	$	11,208
Additions (net of redemption)		579		639		7,564		10,500
Change in fair value of deferred compensation plan assets (Note a)		186		1,204		729		1,972
Closing balance	$	9,906	$	23,680	$	9,906	$	23,680

(a)	Changes in the fair value of plan assets are reported in “other income (expense), net” in the consolidated statements of income.

The following table provides a roll-forward of the fair value of deferred compensation liabilities categorized as level 3 in the fair value hierarchy for the three and nine months ended September 30, 2019 and 2020:

	Three months ended September 30,				Nine months ended September 30,
	2019		2020		2019		2020
Opening balance	$	8,994	$	21,375	$	1,582	$	10,943
Additions (net of redemption)		587		792		7,564		10,367
Change in fair value of deferred compensation plan liabilities (Note a)		61		1,085		496		1,942
Closing balance	$	9,642	$	23,252	$	9,642		23,252

(a)	Changes in the fair value of deferred compensation plan liabilities are reported in “selling, general and administrative expenses” in the consolidated statements of income.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

7.	Derivative financial instruments

The Company is exposed to the risk of rate fluctuations on its foreign currency assets and liabilities and on foreign currency denominated forecasted cash flows and interest rates. The Company has established risk management policies, including the use of derivative financial instruments to hedge foreign currency assets and liabilities, foreign currency denominated forecasted cash flows and interest rate risk. These derivative financial instruments are largely deliverable and non-deliverable forward foreign exchange contracts and interest rate swaps. The Company enters into these contracts with counterparties that are banks or other financial institutions, and the Company considers the risk of non-performance by such counterparties not to be material. The forward foreign exchange contracts and interest rate swaps mature during a period of up to 39 months and the forecasted transactions are expected to occur during the same period.

The following table presents the aggregate notional principal amounts of outstanding derivative financial instruments together with the related balance sheet exposure:

	Notional principal amounts (note a)				Balance sheet exposure asset (liability) (note b)
	As of December 31, 2019		As of September 30, 2020			As of December 31, 2019			As of September 30, 2020
Foreign exchange forward contracts denominated in:
United States Dollars (sell) Indian Rupees (buy)	$	1,305,000	$	1,156,000			(5,740	)	$	(1,200	)
United States Dollars (sell) Mexican Peso (buy)		—		16,500			—			(239	)
United States Dollars (sell) Philippines Peso (buy)		66,600		53,100			462			1,536
Euro (sell) United States Dollars (buy)		122,337		118,678			4,135			(2,457	)
Singapore Dollars (buy) United States Dollars (sell)		10,017		10,017			38			(157	)
Euro (sell) Romanian Leu (buy)		26,918		24,633			(314	)		(190	)
Japanese Yen (sell) Chinese Renminbi (buy)		29,350		18,937			(258	)		121
Pound Sterling (sell) United States Dollars (buy)		9,089		2,278			383			159
Australian Dollars (sell) United States Dollars (buy)		35,972		—			1,924			—
United States Dollars (sell) Hungarian Font (buy)		20,500		39,000			162			(1,034	)
Hungarian Font (Sell) Euro (buy)		9,534		9,971			(157	)		580
Australian Dollars (sell) Indian Rupees (buy)		—		97,038			—			(1,382	)
United States Dollars (Sell) Brazilian Real (buy)		—		1,000			—			(51	)
Interest rate swaps (floating to fixed)		477,604		494,993			(3,565	)		(20,789	)
							(2,930	)		(25,103	)

(a)

Notional amounts are key elements of derivative financial instrument agreements but do not represent the amount exchanged by counterparties and do not measure the Company’s exposure to credit, foreign exchange, interest rate or market risks. However, the amounts exchanged are based on the notional amounts and other provisions of the underlying derivative financial instrument agreements. Notional amounts are denominated in U.S. dollars.

(b)	Balance sheet exposure is denominated in U.S. dollars and denotes the mark-to-market impact of the derivative financial instruments on the reporting date.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

7. Derivative financial instruments (Continued)

FASB guidance on derivatives and hedging requires companies to recognize all derivative instruments as either assets or liabilities at fair value in the balance sheet. In accordance with the FASB guidance on derivatives and hedging, the Company designates foreign exchange forward contracts and interest rate swaps as cash flow hedges. Foreign exchange forward contracts are entered into to cover the effects of future exchange rate variability on forecasted revenues and purchases of services, and interest rate swaps are entered into to cover interest rate fluctuation risk. In addition to this program, the Company uses derivative instruments that are not accounted for as hedges under the FASB guidance in order to hedge foreign exchange risks related to balance sheet items, such as receivables and intercompany borrowings, that are denominated in currencies other than the Company’s underlying functional currency.

The fair value of the Company’s derivative instruments and their location in the Company’s financial statements are summarized in the table below:

	Cash flow hedges				Non-designated
	As of December 31, 2019		As of September 30, 2020		As of December 31, 2019		As of September 30, 2020
Assets
Prepaid expenses and other current assets	$	16,214	$	8,424	$	2,009	$	6,765
Other assets	$	3,086	$	5,498	$	—	$	—

Liabilities
Accrued expenses and other current liabilities	$	6,152	$	27,630	$	814	$	2,079
Other liabilities	$	17,273	$	16,081	$	—	$	—

Cash flow hedges

For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain (loss) on the derivative instrument is reported as a component of other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction is recognized in the consolidated statements of income. Gains (losses) on the derivatives, representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness, are recognized in earnings as incurred.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

7. Derivative financial instruments (Continued)

In connection with cash flow hedges, the gains (losses) recorded as a component of other comprehensive income (loss) (“OCI”), and the related tax effects are summarized below:

	Three months ended September 30,																		Nine months ended September 30,
	2019									2020									2019									2020
	Before Tax amount			Tax (Expense) or Benefit*			Net of tax Amount			Before Tax amount			Tax (Expense) or Benefit*			Net of tax Amount			Before Tax amount			Tax (Expense) or Benefit*			Net of tax Amount			Before Tax amount			Tax (Expense) or Benefit*			Net of tax Amount
Opening balance	$	11,185		$	(6,077	)	$	5,108		$	(54,335	)	$	9,994		$	(44,341	)	$	(2,411	)	$	(5,524	)	$	(7,935	)	$	(4,126	)	$	(1,466	)	$	(5,592	)
Net gains (losses) reclassified into statement of income on completion of hedged transactions		5,915			(1,950	)		3,965			(3,996	)		1,029			(2,967	)		15,105			(5,553	)		9,552			(4,909	)		722			(4,187	)
Changes in fair value of effective portion of outstanding derivatives, net		(9,115	)		1,720			(7,395	)		20,550			(3,661	)		16,889			13,671			(2,436	)		11,235			(30,572	)		7,492			(23,080	)
Gain/(loss) on cash flow hedging derivatives, net		(15,030	)		3,670			(11,360	)		24,546			(4,690	)		19,856			(1,434	)		3,117			1,683			(25,663	)		6,770			(18,893	)
Closing balance	$	(3,845	)	$	(2,407	)	$	(6,252	)	$	(29,789	)	$	5,304		$	(24,485	)	$	(3,845	)	$	(2,407	)	$	(6,252	)	$	(29,789	)	$	5,304		$	(24,485	)

^*The tax (expense) benefit includes the effect of novating certain hedging instruments as part of an intercompany transfer.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

7. Derivative financial instruments (Continued)

The Company’s gains or losses recognized in other comprehensive income (loss) and their effects on financial performance are summarized below:



	Amount of Gain (Loss)												Amount of Gain (Loss) reclassified
	recognized in OCI on												from OCI into Statement of Income
Derivatives in	Derivatives (Effective Portion)											Location of Gain (Loss)	(Effective Portion)
Cash Flow	Three months ended					Nine months ended						reclassified from OCI into	Three months ended					Nine months ended
Hedging	September 30,					September 30,						Statement of Income	September 30,					September 30,
Relationships	2019			2020		2019			2020			(Effective Portion)	2019		2020			2019		2020
Forward foreign exchange contracts	$	(7,261	)	$	20,518	$	22,964		$	(10,609	)	Revenue	$	1,919	$	62		$	4,441	$	3,973
Interest rate swaps		(1,854	)		32		(9,293	)		(19,963	)	Cost of revenue		2,294		(1,571	)		5,274		(4,833	)
												Selling, general and administrative expenses		595		(440	)		1,497		(1,310	)
												Interest expense		1,107		(2,047	)		3,893		(2,739	)
	$	(9,115	)	$	20,550	$	13,671		$	(30,572	)		$	5,915	$	(3,996	)	$	15,105	$	(4,909	)

There were no gains (losses) recognized in income on the ineffective portion of derivatives and excluded from effectiveness testing for the three and nine months ended September 30, 2019 and 2020, respectively.

Non-designated Hedges


		Amount of Gain (Loss) recognized in Statement of Income on Derivatives
		Three months ended September 30,					Nine months ended September 30,
Derivatives not designated as hedging instruments	Location of Gain (Loss) recognized in Statement of Income on Derivatives	2019			2020		2019		2020
Forward foreign exchange contracts (Note a)	Foreign exchange gains (losses), net	$	(3,209	)	$	7,136	$	4,203	$	(6,698	)
Forward foreign exchange contracts (Note b)	Foreign exchange gains (losses), net		—			—		—		3,963
		$	(3,209	)	$	7,136	$	4,203	$	(2,735	)

(a)

These forward foreign exchange contracts were entered into to hedge fluctuations in foreign exchange rates for recognized balance sheet items such as receivables and intercompany borrowings, and were not originally designated as hedges under FASB guidance on derivatives and hedging. Realized gains (losses) and changes in the fair value of these derivatives are recorded in foreign exchange gains (losses), net in the consolidated statements of income.

(b)

These forward foreign exchange contracts were initially designated as cash flow hedges under ASC guidance on derivatives and hedging. These contracts were terminated because certain forecasted transactions were no longer expected to occur and therefore hedge accounting was no longer applied. Subsequently the realized gains (losses) are recorded in foreign exchange gains (losses) net in the consolidated statements of income.

In connection with the COVID-19 pandemic, the Company has reevaluated its hedging arrangements. The Company has considered the effect of changes, if any, in both counterparty credit risk and the Company’s own non-performance risk while assessing hedge effectiveness and measuring hedge ineffectiveness. The Company believes that its hedges continue to be effective after taking into account the expected impact of the COVID-19 pandemic on the Company’s hedged transactions.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

8. Prepaid expenses and other current assets

Prepaid expenses and other current assets consist of the following:

	As of December 31,		As of September 30,
	2019		2020
Advance income and non-income taxes	$	43,763		$	111,902
Contract asset (Note 20)		19,170			13,470
Prepaid expenses		29,734			35,200
Derivative instruments		18,223			15,189
Employee advances		4,209			3,222
Deposits		1,784			6,544
Advances to suppliers		4,289			738
Others		49,153			29,979
	$	170,325		$	216,244

9. Property, plant and equipment, net

The following table provides the gross and net amount of property, plant and equipment:

	As of December 31, 2019			As of September 30, 2020
Property, plant and equipment, gross	$	744,161		$	769,214
Less: Accumulated depreciation, amortization and impairment		(490,126	)		(531,741	)
Property, plant and equipment, net	$	254,035		$	237,473

Depreciation expense on property, plant and equipment for the nine months ended September 30, 2019 and 2020 was $41,739 and $50,863, respectively, and for the three months ended September 30, 2019 and 2020 was $13,262 and $17,257, respectively. Computer software amortization for the nine months ended September 30, 2019 and 2020 was $8,060 and $7,399, respectively, and for the three months ended September 30, 2019 and 2020 was $3,844 and $1,889, respectively.

The depreciation and amortization expenses set forth above include the effect of the reclassification of foreign exchange (gains) losses related to the effective portion of foreign currency derivative contracts, amounting to $(224) and $223 for the nine months ended September 30, 2019 and 2020, respectively, and $(94) and $68 for the three months ended September 30, 2019 and 2020, respectively.

The Company recorded a write-down to certain property, plant and equipment during the three and nine months ended September 30, 2020, as described in Note 10.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

10. Goodwill and intangible assets

The following table presents the changes in goodwill for the year ended December 31, 2019 and nine months ended September 30, 2020:

	For the year ended December 31, 2019		For the nine months ended September 30, 2020
Opening balance	$	1,393,832	$	1,574,466
Goodwill relating to acquisitions consummated during the period		185,381		—
Impact of measurement period adjustments		(988)		—
Effect of exchange rate fluctuations		(3,759)		(6,863)
Closing balance	$	1,574,466	$	1,567,603

The following table presents the changes in goodwill by reporting unit for the nine months ended September 30, 2020:

	BCMI			CGRLH			HMS			Total
Opening balance	$	417,213			555,130			602,123			1,574,466
Goodwill relating to acquisitions consummated during the period		—			—			—			—
Impact of measurement period adjustments		—			—			—			—
Effect of exchange rate fluctuations		(1,971	)		(2,519	)		(2,373	)		(6,863	)
Closing balance	$	415,242			552,611			599,750			1,567,603

The following table presents the changes in goodwill by reporting unit for the year ended December 31, 2019:

	BCMI			CGRLH			HMS			Total
Opening balance	$	398,601			512,296			482,935			1,393,832
Goodwill relating to acquisitions consummated during the period		20,072			44,365			120,944			185,381
Impact of measurement period adjustments		(380	)		(151	)		(457	)		(988	)
Effect of exchange rate fluctuations		(1,080	)		(1,380	)		(1,299	)		(3,759	)
Closing balance	$	417,213			555,130			602,123			1,574,466

The total amount of goodwill deductible for tax purposes was $282,524 and $265,924 as of December 31, 2019 and September 30, 2020, respectively.

The Company’s intangible assets are as follows:

	As of December 31, 2019						As of September 30, 2020
	Gross carrying amount		Accumulated amortization & Impairment		Net		Gross carrying amount		Accumulated amortization & Impairment		Net
Customer-related intangible assets	$	415,375		329,724		85,651		413,057		348,267		64,790
Marketing-related intangible assets		84,180		50,217		33,963		83,202		57,969		25,233
Technology-related intangible assets		149,262		61,150		88,112		150,345		83,010		67,335
Intangible assets under development		26,646		3,511		23,135		22,053		2,503		19,550
		675,463		444,602		230,861		668,657		491,749		176,908

Amortization expenses for intangible assets acquired as a part of business combination and disclosed in the consolidated statements of income under amortization of acquired intangible assets for the nine months ended September 30, 2019 and 2020 were $23,565 and $31,673, respectively, and for the three months ended September 30, 2019 and 2020 were $6,960 and $10,235, respectively.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

10. Goodwill and intangible assets (Continued)

Amortization expenses for internally-developed and other intangible assets disclosed in the consolidated statements of income under cost of revenue and selling, general and administrative expenses for the nine months ended September 30, 2019 and 2020 were $13,244 and $20,932, respectively, and for the three months ended September 30, 2019 and 2020 were $4,990 and $6,896, respectively.

Amortization expenses for the technology-related, internally-developed intangible assets set forth above include the effect of the reclassification of foreign exchange (gains) losses related to the effective portion of foreign currency derivative contracts, amounting to $(62) and $79 for the nine months ended September 30, 2019 and 2020, respectively, and $(27) and $26 for the three months ended September 30, 2019 and 2020, respectively.

During the three and nine months ended September 30, 2019 and 2020, the Company tested for recoverability certain customer-related and technology-related intangible assets, including those under development, and certain property, plant and equipment, as a result of changes in the Company’s investment strategy and market trends which led to a decision to cease certain service offerings. Based on the results of this testing, the Company determined that the carrying values of the assets tested were not recoverable, and the Company recorded complete write-downs of the carrying values of these assets amounting to $3,511 and $10,647 for the nine months ended September 30, 2019 and 2020, respectively, and $0 and $674 for the three months ended September 30, 2019 and 2020, respectively. These write-downs have been recorded in “other operating (income) expense, net” in the consolidated statement of income.

The summary below represents the impairment charge recorded for various categories of assets during the three and nine months ended September 30, 2019 and September 30, 2020:

	Three months ended September 30,			Nine months ended September 30,
	2019	2020		2019		2020
Technology related intangibles	—		347		3,511		4,878
Customer related intangibles	—	—		—			1,239
Total Intangibles	—		347		3,511		6,117
Property, plant and equipment	—		327	—			4,530
Total Property, plant and equipment	—		327	—			4,530
Grand Total	—		674		3,511		10,647

11. Short-term borrowings

The Company has the following borrowing facilities:

(a)

Fund-based and non-fund-based credit facilities with banks, which are available for operational requirements in the form of overdrafts, letters of credit, guarantees and short-term loans. As of December 31, 2019 and September 30, 2020, the limits available were $14,307 and $14,212, respectively, of which $7,486 and $6,191, respectively, was utilized, constituting non-funded drawdown.

(b)

A fund-based and non-fund based revolving credit facility of $500,000, which the Company obtained through an amendment of its existing credit agreement on August 9, 2018, as described in Note 12. Prior to the amendment, the Company’s revolving credit facility was $350,000. The amended credit facility expires on August 8, 2023. The funded drawdown amount under the Company’s revolving facilities bore interest at a rate equal to LIBOR plus a margin of 1.375% as of December 31, 2019 and September 30, 2020. The unutilized amount on the revolving facilities bore a commitment fee of 0.20% as of December 31, 2019 and September 30, 2020. As of December 31, 2019 and September 30, 2020, a total of $72,098 and $247,639, respectively, was utilized, of which $70,000 and $245,000, respectively, constituted funded drawdown and $2,098 and $2,639, respectively, constituted non-funded drawdown. The Company’s amended credit agreement contains certain customary covenants, including a maximum leverage covenant and a minimum interest coverage ratio. During the period ended September 30, 2020, the Company was in compliance with the financial covenants of the credit agreement.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

12. Long-term debt

In August 2018, the Company amended its 2015 credit facility (“the 2015 Facility”), which was comprised of an $800,000 term loan and a $350,000 revolving credit facility. The amended facility is comprised of a $680,000 term loan, which represents the outstanding balance under the 2015 Facility as of the date of amendment, and a $500,000 revolving credit facility. The amended facility expires on August 8, 2023. The amendment did not result in a substantial modification of $550,814 of the outstanding term loan under the 2015 Facility. Further, as a result of the amendment, the Company extinguished the outstanding term loan under the 2015 Facility of $129,186 and obtained additional funding of $129,186, resulting in no change to the outstanding principal of the term loan under the amended facility. In connection with the amendment, the Company expensed $2,029, representing partial acceleration of the amortization of the existing unamortized debt issuance costs and an additional fee paid to the Company’s lenders related to the term loan. The overall borrowing capacity under the revolving credit facility increased from $350,000 to $500,000. The amendment of the revolving credit facility resulted in accelerated amortization of $82 relating to existing unamortized debt issuance cost. The remaining unamortized costs and an additional third-party fee paid in connection with the amendment will be amortized over the term of the amended facility, which will expire on August 8, 2023.

Borrowings under the amended credit facility bear interest at a rate equal to, at the election of the Company, either LIBOR plus an applicable margin equal to 1.375% per annum, compared to a margin of 1.50% under the 2015 Facility, or a base rate plus an applicable margin equal to 0.375% per annum, compared to a margin of 0.50% under the 2015 Facility, in each case subject to adjustment based on the Company’s debt ratings provided by Standard & Poor’s Rating Services and Moody’s Investors Service, Inc. Based on the Company’s election and current credit rating, the applicable interest rate is equal to LIBOR plus 1.375% per annum. The amended credit agreement restricts certain payments, including dividend payments, if there is an event of default under the credit agreement or if the Company is not, or after making the payment would not be, in compliance with certain financial covenants contained in the amended credit agreement. These covenants require the Company to maintain a net debt to EBITDA leverage ratio of below 3x and an interest coverage ratio of more than 3x. During the period ended September 30, 2020, the Company was in compliance with the terms of the credit agreement, including all of the financial covenants therein. The Company’s retained earnings are not subject to any restrictions on availability to make dividend payments to shareholders, subject to compliance with the financial covenants described above that are contained in the amended credit agreement.

As of December 31, 2019 and September 30, 2020, the amount outstanding under the term loan, net of debt amortization expense of $1,641 and $1,271, was $627,359 and $602,229, respectively. As of December 31, 2019 and September 30, 2020, the term loan bore interest at a rate equal to LIBOR plus a margin of 1.375% per annum. Indebtedness under the amended credit facility is unsecured. The amount outstanding on the term loan as of September 30, 2020 requires quarterly payments of $8,500, and the balance of the loan is due and payable upon the maturity of the term loan on August 8, 2023.

The maturity profile of the term loan outstanding as of September 30, 2020, net of debt amortization expense, is as follows:

Year ended	Amount
2020	$	8,379
2021		33,537
2022		33,564
2023		526,749
Total	$	602,229

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

12. Long-term debt (Continued)

Genpact Luxembourg S.à.r.l. (the “Issuer”), a wholly owned subsidiary of the Company, issued $350,000 aggregate principal amount of 3.70% senior notes in March 2017 (the “2017 Senior Notes”), and $400,000 aggregate principal amount of 3.375% senior notes in November 2019 (the “2019 Senior Notes” and together with the 2017 Senior Notes, the “Senior Notes”). The Senior Notes are fully guaranteed by the Company. The total debt issuance cost of $2,642 and $2,937 incurred in connection with the 2017 Senior Notes and 2019 Senior Notes offerings, respectively, are being amortized over the lives of the Senior Notes as an additional interest expense. As of December 31, 2019 and September 30, 2020, the amount outstanding under the 2017 Senior Notes, net of debt amortization expense of $1,186 and $791, respectively, was $348,814 and $349,209, respectively, which is payable on April 1, 2022. As of December 31, 2019 and September 30, 2020, the amount outstanding under the 2019 Senior Notes, net of debt amortization expense of $2,868 and $2,431, was $397,132 and $397,569, respectively. The Issuer will pay interest on the 2017 Senior Notes semi-annually in arrears on April 1 and October 1 of each year and on the 2019 Senior Notes semi-annually in arrears on June 1 and December 1 of each year, ending on the maturity dates of April 1, 2022 and December 1, 2024, respectively. The Company, at its option, may redeem the Senior Notes at any time in whole or in part, at a redemption price equal to (i) 100% of the principal amount of the notes redeemed, together with accrued and unpaid interest on the redeemed amount, and (ii) if the notes are redeemed prior to, in the case of the 2017 Senior Notes, March 1, 2022, and in the case of the 2019 Senior Notes, November 1, 2024, a specified “make-whole” premium. The Senior Notes are subject to certain customary covenants, including limitations on the ability of the Company and certain of its subsidiaries to incur debt secured by liens, engage in certain sale and leaseback transactions and consolidate, merge, convey or transfer their assets. During the period ended September 30, 2020, the Company and its applicable subsidiaries were in compliance with the covenants. Upon certain change of control transactions, the Issuer will be required to make an offer to repurchase the notes at a price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest. The interest rate payable on the notes is subject to adjustment if the credit rating of the notes is downgraded, up to a maximum increase of 2.0%.

A summary of the company’s long-term debt is as follows:

	As of December 31, 2019		As of September 30, 2020
Credit facility, net of debt amortization expense		627,359		602,229
2017 Senior Notes, net of debt amortization expense		348,814		349,209
2019 Senior Notes, net of debt amortization expense		397,132		397,569
Total	$	1,373,305	$	1,349,007
Current portion		33,509		33,530
Non-current portion		1,339,796		1,315,477
Total	$	1,373,305	$	1,349,007

13. Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consist of the following:

	As of December 31,		As of September 30,
	2019		2020
Accrued expenses	$	178,845	$	153,235
Accrued employee cost		273,769		211,312
Earn-out consideration		6,384		5,001
Statutory liabilities		62,786		68,724
Retirement benefits		1,564		1,617
Compensated absences		26,116		28,220
Derivative instruments		6,966		29,709
Contract liabilities (Note 20)		97,313		132,754
Finance lease liability		9,740		16,211
Others		20,388		30,647
	$	683,871	$	677,430

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

14. Other liabilities

Other liabilities consist of the following:

	As of December 31,		As of September 30,
	2019		2020
Accrued employee cost	$	8,729	$	18,900
Earn-out consideration		15,800		13,161
Statutory liabilities		66		21,748
Retirement benefits		13,162		17,274
Compensated absences		35,029		43,384
Derivative instruments		17,273		16,081
Contract liabilities (Note 20)		78,613		65,779
Finance lease liability		20,725		31,249
Others		19,519		28,445
	$	208,916	$	256,021

15. Employee benefit plans

The Company has employee benefit plans in the form of certain statutory and other programs covering its employees.

Defined benefit plans

In accordance with Indian law, the Company maintains a defined benefit retirement plan covering substantially all of its Indian employees. In accordance with Mexican law, the Company provides termination benefits to all of its Mexican employees. In addition, certain of the Company’s subsidiaries in the Philippines, Israel and Japan sponsor defined benefit retirement programs.

Net defined benefit plan costs for the three and nine months ended September 30, 2019 and 2020 include the following components:

	Three months ended September 30,							Nine months ended September 30,
	2019			2020			2019				2020
Service costs	$	2,108		$	2,733		$		6,439		$	8,402
Interest costs		1,138			1,267				3,479			3,898
Amortization of actuarial loss		290			615				887			1,883
Expected return on plan assets		(643	)		(1,108	)			(1,967	)		(3,406	)
Net defined benefit plan costs	$	2,893		$	3,507		$		8,838		$	10,777

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

15. Employee benefit plans (Continued)

Defined contribution plans

During the three and nine months ended September 30, 2019 and 2020, the Company contributed the following amounts to defined contribution plans in various jurisdictions:

	Three months ended September 30,				Nine months ended September 30,
	2019		2020		2019		2020
India	$	7,805	$	7,289	$	21,757	$	22,362
U.S.		4,655		4,654		13,676		13,935
U.K.		2,634		2,836		9,290		8,719
China		4,693		4,691		14,111		11,953
Other regions		1,388		2,628		4,244		7,464
Total	$	21,175	$	22,098	$	63,078	$	64,433

Deferred compensation plan

On July 1, 2018, Genpact LLC, a wholly-owned subsidiary of the Company, adopted an executive deferred compensation plan (the “Plan”). The Plan provides a select group of U.S.-based members of Company management with the opportunity to defer from 1% to 80% of their base salary and from 1% to 100% of their qualifying bonus compensation (or such other minimums or maximums as determined by the Plan administrator from time to time) pursuant to the terms of the Plan. Participant deferrals are 100% vested at all times. The Plan also allows for discretionary supplemental employer contributions by the Company, in its sole discretion, which will be subject to a two-year vesting schedule (50% vesting on the one-year anniversary of approval of the contribution and 50% vesting on the second year anniversary of approval of the contribution) or such other vesting schedule as determined by the Company. However, no such contribution has been made by the Company to date.

The Plan also provides an option for participants to elect to receive deferred compensation and earnings thereon on either fixed date(s) no earlier than two years following the applicable Plan year (or end of the applicable performance period for performance-based bonus compensation) or following a separation from service, in each case either in a lump sum or in annual installments over a term of up to 15 years. Each Plan participant’s compensation deferrals are credited or debited with notional investment gains and losses equal to the performance of selected hypothetical investment funds offered under the Plan and elected by the participant.

The Company has investments in funds held in Company-owned life insurance policies which are held in a Rabbi Trust that are classified as trading securities. Management determines the appropriate classification of the securities at the time they are acquired and evaluates the appropriateness of such classifications at each balance sheet date. The securities are classified as trading securities because they are held for resale in anticipation of short-term fluctuations in market prices. The trading securities are stated at fair value.

The liability for the deferred compensation plan was $10,943 and $23,252 as of December 31, 2019 and September 30, 2020, respectively, and is included in “accrued expenses and other current liabilities” and “other liabilities” in the consolidated balance sheets.

In connection with the administration of the Plan, the Company has purchased company-owned life insurance policies insuring the lives of certain employees. The cash surrender value of these policies was $11,208 and $23,680 as of December 31, 2019 and September 30, 2020, respectively. The cash surrender value of these insurance policies is included in “other assets” in the consolidated balance sheets.

During the nine months ended September 30, 2019 and 2020, the change in the fair value of Plan assets was $729 and $1,972, respectively, and for the three months ended September 30, 2019 and 2020 was $186 and $1,204, respectively, which is included in “other income (expense), net,” in the consolidated statements of income. During the nine months ended September 30, 2019 and 2020, the change in the fair value of deferred compensation liabilities was $496 and $1,942, respectively, and for the three months ended September, 30 2019 and 2020 was $61 and $1,085, respectively, which is included in “selling, general and administrative expenses.”

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

16. Stock-based compensation

The Company has issued options under the Genpact Limited 2007 Omnibus Incentive Compensation Plan (the “2007 Omnibus Plan”) and the Genpact Limited 2017 Omnibus Incentive Compensation Plan (the “2017 Omnibus Plan”) to eligible persons, including employees, directors and certain other persons associated with the Company.

Under the 2007 Omnibus Plan, shares underlying options forfeited, expired, terminated or cancelled under any of the Company’s predecessor plans were added to the number of shares otherwise available for grant under the 2007 Omnibus Plan. The 2007 Omnibus Plan was amended and restated on April 11, 2012 to increase the number of common shares authorized for issuance by 5,593,200 shares to 15,000,000 shares.

On May 9, 2017, the Company’s shareholders approved the adoption of the 2017 Omnibus Plan, pursuant to which 15,000,000 Company common shares are available for issuance. The 2017 Omnibus Plan was amended and restated on April 5, 2019 to increase the number of common shares authorized for issuance by 8,000,000 shares to 23,000,000 shares. No grants may be made under the 2007 Omnibus Plan after the date of adoption of the 2017 Omnibus Plan. Grants that were outstanding under the 2007 Omnibus Plan as of the date of Company’s adoption of the 2017 Omnibus Plan remain subject to the terms of the 2007 Omnibus Plan.

Stock-based compensation costs relating to the foregoing plans during the nine months ended September 30, 2019 and September 30, 2020 were $60,525 and $54,835, respectively, and for the three months ended September 30, 2019 and 2020 were $21,042 and $19,180, respectively. These costs have been allocated to “cost of revenue” and “selling, general and administrative expenses.”

Stock options

All options granted under the 2007 and 2017 Omnibus Plans are exercisable into common shares of the Company, have a contractual period of ten years and vest over four to five years unless specified otherwise in the applicable award agreement. The Company recognizes compensation cost over the vesting period of the option.

Compensation cost is determined at the date of grant by estimating the fair value of an option using the Black-Scholes option-pricing model.

The following table shows the significant assumptions used in determining the fair value of options granted in the nine months ended September 30, 2019 and 2020. The Company granted 1,881,068 options in the nine months ended September 30, 2019.

	Nine months ended September 30, 2019		Nine months ended September 30, 2020
Dividend yield	0.82% - 1.08%			0.89	%
Expected life (in months)		84		84
Risk-free rate of interest	1.56% - 2.63%			1.50	%
Volatility	21.0% - 21.38%			20.96	%

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

16. Stock-based compensation (Continued)

A summary of stock option activity during the nine months ended September 30, 2020 is set out below:

	Nine months ended September 30, 2020
	Shares arising out of options			Weighted average exercise price		Weighted average remaining contractual life (years)			Aggregate intrinsic value
Outstanding as of January 1, 2020		8,360,212		$	25.33			6.5	$		—
Granted		431,924			43.94			—			—
Forfeited		(752,261)			30.09			—			—
Expired		—			—			—			—
Exercised		(542,634	)		20.03			—			8,802
Outstanding as of September 30, 2020		7,497,241		$	26.31			5.9	$		96,908
Vested as of September 30, 2020 and expected to vest thereafter (Note a)	7,311,736			$	26.19		5.9		$	95,303
Vested and exercisable as of September 30, 2020		2,863,405		$	19.50			2.9	$		55,703
Weighted average grant date fair value of grants during the period	$	9.72

(a)	Options expected to vest reflect an estimated forfeiture rate.

As of September 30, 2020, the total remaining unrecognized stock-based compensation cost for options expected to vest amounted to $21,480, which will be recognized over the weighted average remaining requisite vesting period of 3.1 years.

Restricted share units

The Company has granted restricted share units (“RSUs”) under the 2007 and 2017 Omnibus Plans. Each RSU represents the right to receive one common share. The fair value of each RSU is the market price of one common share of the Company on the date of the grant. The RSUs granted to date have graded vesting schedules of three months to four years. The compensation expense is recognized on a straight-line basis over the vesting term. A summary of RSU activity during the nine months ended September 30, 2020 is set out below:

	Nine months ended September 30, 2020
	Number of Restricted Share Units		Weighted Average Grant Date Fair Value
Outstanding as of January 1, 2020		1,261,706	$	31.41
Granted		296,332		40.40
Vested (Note a)		(582,608)		27.77
Forfeited		(57,052)		37.45
Outstanding as of September 30, 2020		918,378	$	36.24
Expected to vest (Note b)		814,622

(a)	582,608 RSUs that vested during the period were net settled upon vesting by issuing 336,460 shares (net of minimum statutory tax withholding).

(b)	The number of RSUs expected to vest reflects the application of an estimated forfeiture rate.

44,562 RSUs vested in the year ended December 31, 2018, in respect of which 44,165 shares were issued during the nine months ended September 30, 2020 after withholding shares to the extent required to satisfy minimum statutory withholding obligations.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

16. Stock-based compensation (Continued)

As of September 30, 2020, the total remaining unrecognized stock-based compensation cost related to RSUs amounted to $20,611, which will be recognized over the weighted average remaining requisite vesting period of 2.1 years.

Performance units

The Company also grants stock awards in the form of performance units (“PUs”) and has granted PUs under both the 2007 and 2017 Omnibus Plans.

Each PU represents the right to receive one common share at a future date based on the Company’s performance against specified targets. PUs granted to date have vesting schedules of six months to three years. The fair value of each PU is the market price of one common share of the Company on the date of grant and assumes that performance targets will be achieved. PUs granted under the plans are subject to cliff vesting. The compensation expense for such awards is recognized on a straight-line basis over the vesting terms. During the performance period, the Company’s estimate of the number of shares to be issued is adjusted upward or downward based upon the probability of achievement of the performance targets. The ultimate number of shares issued and the related compensation cost recognized is based on a comparison of the final performance metrics to the specified targets.

A summary of PU activity during the nine months ended September 30, 2020 is set out below:

	Nine months ended Sept 30, 2020
	Number of Performance Units		Weighted Average Grant Date Fair Value		Maximum Shares Eligible to Receive
Outstanding as of January 1, 2020		6,058,464	$	31.07		6,058,464
Granted		1,253,766		42.49		2,507,532
Vested (Note a)		(1,496,377)		25.21		(1,496,377)
Forfeited		(494,654)		33.65		(511,928)
Adjustment upon final determination of level of performance goal achievement (Note b)		6,503		34.72		6,503
Outstanding as of September 30, 2020		5,327,702	$	35.17		6,564,194
Expected to vest (Note c)		4,699,601

(a)	1,496,377 PSUs that vested during the period were net settled upon vesting by issuing 902,532 shares (net of minimum statutory tax withholding).

(b)	Represents an adjustment made in March 2020 to the number of shares subject to the PUs granted in 2019 upon certification of the level of achievement of the performance targets underlying such awards.

(c)	The number of PUs expected to vest reflects the application of an estimated forfeiture rate.

As of September 30, 2020, the total remaining unrecognized stock-based compensation cost related to PUs amounted to $66,107, which will be recognized over the weighted average remaining requisite vesting period of 1.6 years.

Employee Stock Purchase Plan (ESPP)

On May 1, 2008, the Company adopted the Genpact Limited U.S. Employee Stock Purchase Plan and the Genpact Limited International Employee Stock Purchase Plan (together, the “ESPP”). In April 2018, these plans were amended and restated, and their terms were extended to August 31, 2028.

The ESPP allows eligible employees to purchase the Company’s common shares through payroll deductions at 90% of the closing price of the Company’s common shares on the last business day of each purchase interval. The dollar amount of common shares purchased under the ESPP may not exceed 15% of the participating employee’s base salary, subject to a cap of $25 per employee per calendar year. With effect from September 1, 2009, the offering periods commence on the first business day in March, June, September and December of each year and end on the last business day of the subsequent May, August, November and February. 4,200,000 common shares have been reserved for issuance in the aggregate over the term of the ESPP.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

16. Stock-based compensation (Continued)

During the nine months ended September 30, 2019 and 2020, 195,221 and 241,953 common shares, respectively, were issued under the ESPP.

The ESPP is considered compensatory under the FASB guidance on Compensation-Stock Compensation.

The compensation expense for the ESPP is recognized in accordance with the FASB guidance on Compensation-Stock Compensation. The compensation expense for the ESPP during the nine months ended September 30, 2019 and 2020 was $782 and $983, respectively, and for the three months ended September 30, 2019 and 2020 was $278 and $307 , respectively, and has been allocated to cost of revenue and selling, general and administrative expenses.

17. Capital stock

Share repurchases

The Board of Directors of the Company (the “Board”) has authorized repurchases of up to $1,250,000 under the Company’s existing share repurchase program. The Company’s share repurchase program does not obligate it to acquire any specific number of shares. Under the program, shares may be purchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

During the nine months ended September 30, 2019 and 2020, the Company repurchased 608,285 and 1,781,978 of its common shares, respectively, on the open market at a weighted average price of $39.29 and $41.28 per share, respectively, for an aggregate cash amount of $23,901 and $73,552, respectively. All repurchased shares have been retired.

The Company records repurchases of its common shares on the settlement date of each transaction. Shares purchased and retired are deducted to the extent of their par value from common stock and from retained earnings for the excess over par value. Direct costs incurred to acquire the shares are included in the total cost of the shares purchased. For the nine months ended September 30, 2019 and 2020, retained earnings were reduced by the direct costs related to share repurchases of $12 and $36, respectively.

Approximately $200,491 remained available for share repurchases under the Company’s existing share repurchase program as of September 30, 2020. This repurchase program does not obligate the Company to acquire any specific number of shares and does not specify an expiration date.

Dividend

On February 7, 2019, the Company announced that its Board had approved a 13% increase in its quarterly cash dividend to $0.085 per share, up from $0.075 per share in 2018, representing an annual dividend of $0.34 per common share, up from $0.30 per share in 2018, payable to holders of the Company’s common shares. On March 20, 2019, June 21, 2019 and September 20, 2019, the Company paid a dividend of $0.085 per share, amounting to $16,119, $16,188 and $16,208 in the aggregate, to shareholders of record as of March 8, 2019, June 12, 2019 and September 11, 2019, respectively.

On February 6, 2020, the Company announced that its Board had approved a 15% increase in its quarterly cash dividend to $0.0975 per share, up from $0.085 per share in 2019, representing a planned annual dividend of $0.39 per common share, up from $0.34 per share in 2019, payable to holders of the Company’s common shares. On March 18, 2020, June 26, 2020 and September 23, 2020, the Company paid a dividend of $0.0975 per share, amounting to $18,543, $18,595 and $18,637 in the aggregate, to shareholders of record as of March 9, 2020, June 11, 2020 and September 11, 2020, respectively.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

18. Earnings per share

The Company calculates earnings per share in accordance with FASB guidance on earnings per share. Basic and diluted earnings per common share give effect to the change in the number of Company common shares outstanding. The calculation of basic earnings per common share is determined by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the respective periods. The potentially dilutive shares, consisting of outstanding options on common shares, restricted share units, common shares to be issued under the ESPP and performance units, have been included in the computation of diluted net earnings per share and the number of weighted average shares outstanding, except where the result would be anti-dilutive.

The number of shares subject to stock awards outstanding but not included in the computation of diluted earnings per common share because their effect was anti-dilutive is 2,375,425 and 1,432,789 for the nine months ended September 30, 2019 and 2020, respectively, and 60,194 and 675,214 for the three months ended September 30, 2019 and 2020, respectively.

	Three months ended September 30,				Nine months ended September 30,
	2019		2020		2019		2020
Net income available to Genpact Limited common shareholders	$	88,120	$	85,435	$	222,683	$	233,294
Weighted average number of common shares used in computing basic earnings per common share		190,599,049		190,949,108		190,071,418		190,705,671
Dilutive effect of stock-based awards		5,291,792		5,706,032		4,612,281		5,394,396
Weighted average number of common shares used in computing dilutive earnings per common share		195,890,841		196,655,140		194,683,699		196,100,067
Earnings per common share attributable to Genpact Limited common shareholders
Basic	$	0.46	$	0.45	$	1.17	$	1.22
Diluted	$	0.45	$	0.43	$	1.14	$	1.19

19. Segment reporting

The Company manages various types of business process and information technology services in an integrated manner for clients in various industries and geographic locations. The Company's operating segments are significant strategic business units that align its products and services with how it manages its business, approaches key markets and interacts with its clients. Effective from the quarter and year ended December 31, 2019, the Company implemented operational changes in how its Chief Operating Decision Maker (“CODM”) manages its businesses, including resource allocation and performance assessment. As a result of these changes, the Company now has three operating segments, representing the individual businesses that are run separately under the new structure.

The Company’s reportable segments are as follows: (1) Banking, Capital Markets and Insurance (“BCMI”); (2) Consumer Goods, Retail, Life Sciences and Healthcare (“CGRLH”); and (3) High Tech, Manufacturing and Services (“HMS”).

The Company has restated segment information for the historical periods presented herein to conform to the current presentation. This change in segment presentation does not affect the Company's consolidated statements of income, balance sheets or statements of cash flows.

The Company’s Chief Executive Officer, who has been identified as the CODM, reviews operating segment revenue, which is a GAAP measure, and operating segment adjusted income from operations, which is a non-GAAP measure. The Company does not allocate and therefore the CODM does not evaluate foreign exchange gain/(losses), interest income/(expense), restructuring expenses, acquisition related expenses, other income/(expense), or income taxes by segment. The Company’s operating assets and liabilities pertain to multiple segments. The Company manages assets and liabilities on a total company basis, not by operating segment, and therefore asset and liabilities information and capital expenditures by operating segment are not presented to the CODM and are not reviewed by the CODM.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

19. Segment reporting (Continued)

Revenues and adjusted income from operations for each of the Company’s segments for the three months ended September 30, 2020 were as follows:

	Reportable segments
	BCMI		CGRLH		HMS		Others*			Total
Revenues, net		283,806		318,290		339,008		(5,581	)		935,523
Adjusted income from operations		38,771		47,847		60,990		12,365			159,973
Stock-based compensation											(19,487	)
Amortization and impairment of acquired intangible assets (other than included above)											(9,995	)
Foreign exchange gains (losses), net											(2,402	)
Interest income (expense), net											(12,757	)
Restructuring expenses (refer (a) below and note 27)											(4,889	)
Income tax expense											(25,008	)
Net income											85,435

(a)	We do not allocate these charges to individual segments in internal management reports used by the chief operating decision maker. Accordingly, such expenses are included in our segment reporting as “unallocated costs.”

*Revenues, net for “Others” primarily represents the impact of foreign exchange fluctuations, which is not allocated to the Company’s segments for management’s internal reporting purposes. Adjusted income from operations for “Others” primarily represents the impact of over-absorption of overhead, unallocated allowance for credit losses and foreign exchange fluctuations, which are not allocated to the Company’s segments for management’s internal reporting purposes.

Revenues and adjusted income from operations for each of the Company’s segments for the nine months ended September 30, 2020 were as follows:

	Reportable segments
	BCMI		CGRLH		HMS		Others**			Total
Revenues, net		805,807		930,203		1,045,920		(23,121	)		2,758,809
Adjusted income from 0perations		88,888		134,691		178,741		38,873			441,193
Stock-based compensation											(55,818	)
Amortization and impairment of acquired intangible assets (other than included above)											(32,218	)
Foreign exchange gains (losses), net											11,611
Interest income (expense), net											(38,072	)
Restructuring expenses (refer (b) below and note 27)											(26,547	)
Income tax expense											(66,855	)
Net income											233,294

(b)	We do not allocate these charges to individual segments in internal management reports used by the chief operating decision maker. Accordingly, such expenses are included in our segment reporting as “unallocated costs.”

**Revenues, net for “Others” primarily represents the impact of foreign exchange fluctuations, which is not allocated to the Company’s segments for management’s internal reporting purposes. Adjusted income from operations for “Others” primarily represents the impact of over-absorption of overhead, unallocated allowance for credit losses and foreign exchange fluctuations, which are not allocated to the Company’s segments for management’s internal reporting purposes.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

19. Segment reporting (Continued)

Revenues and adjusted income from operations for each of the Company’s segments for the three months ended September 30, 2019 were as follows:

	Reportable segments
	BCMI		CGRLH		HMS		Others#			Total
Revenues, net		282,158		273,077		338,172		(4,608	)		888,799
Adjusted income from operations		32,683		42,697		58,520		8,415			142,315
Stock-based compensation											(21,320	)
Amortization of acquired intangible assets (other than included above)											(6,712	)
Foreign exchange gains (losses), net											6,727
Interest income (expense), net											(10,221	)
Income tax expense											(22,669	)
Net income											88,120

#Revenues, net for “Others” primarily represents the impact of foreign exchange fluctuations, which is not allocated to the Company’s segments for management’s internal reporting purposes. Adjusted income from operations for “Others” primarily represents the impact of over-absorption of overhead and foreign exchange fluctuations, which are not allocated to the Company’s segments for management’s internal reporting purposes.

Revenues and adjusted income from operations for each of the Company’s segments for the nine months ended September 30, 2019 were as follows:

	Reportable segments
	BCMI		CGRLH		HMS		Others##			Total
Revenues, net		798,171		802,714		988,691		(9,773	)		2,579,804
Adjusted income from operations		88,796		115,243		175,285		20,548			399,872
Stock-based compensation											(61,307	)
Amortization of acquired intangible assets (other than included above)											(22,689	)
Acquisition-related expenses											(967	)
Foreign exchange gains (losses), net											3,646
Interest income (expense), net											(33,487	)
Income tax expense											(62,385	)
Net income											222,683

##Revenues, net for “Others” primarily represents the impact of foreign exchange fluctuations, which is not allocated to the Company’s segments for management’s internal reporting purposes. Adjusted income from operations for “Others” primarily represents the impact of over-absorption of overhead and foreign exchange fluctuations, which are not allocated to the Company’s segments for management’s internal reporting purposes.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

20. Net revenues

Disaggregation of revenue

In the following table, the Company’s revenue is disaggregated by customer classification:

	Three months ended September 30,				Nine months ended September 30,
	2019		2020		2019		2020
GE	$	121,096	$	111,348	$	348,742	$	349,762
Global clients		767,703		824,175		2,231,062		2,409,047
Total net revenues	$	888,799	$	935,523	$	2,579,804	$	2,758,809

All revenue from GE is included in revenue from the HMS segment, and the remainder of revenue from the HMS segment consists of revenue from Global Clients. All of the segment revenue from both the BCMI and CGRLH segments consists of revenue from Global Clients. Refer to Note 19 for details on net revenues attributable to each of the Company’s segments.

The Company has evaluated the impact of the COVID-19 pandemic on the Company’s net revenues for the three and nine months ended September 30, 2020 to ensure that revenue is recognized after considering all impacts to the extent currently known. Impacts observed include constraints on the Company’s ability to render services, whether due to full or partial shutdowns of the Company’s facilities or significant travel restrictions, penalties relating to breaches of service level agreements, and contract terminations or contract performance delays initiated by clients. The Company’s net revenues for the three and nine months ended September 30, 2020 were lower than expected before the onset of the pandemic, primarily due to delays in obtaining client approvals to shift to a virtual, work-from-home operating environment, whether as a result of regulatory constraints or due to privacy or security concerns. The Company’s net revenues from various service lines, including transformation services, were also lower than originally expected before the onset of the pandemic in the three and nine months ended September 30, 2020 due to adverse market developments related to the pandemic, resulting in instances of delayed or canceled new projects and new orders. Due to the nature of the pandemic, the Company will continue to monitor developments to identify significant uncertainties relating to revenue in future periods.

Contract balances

Accounts receivable include amounts for services that the Company has performed but for which payment has not been received. The Company typically follows a 30-day billing cycle and, as such, at any point in time may have accrued up to 30 days of revenues that have not been billed. The Company has determined that in instances where the timing of revenue recognition differs from the timing of invoicing, the related contracts generally do not include a significant financing component. Refer to Note 5 for details on the Company’s accounts receivable and allowance for credit losses.

The following table shows the details of the Company’s contract balances:

Particulars	As of December 31, 2019		As of September 30, 2020
Contract assets (Note a)	$	40,346	$	31,195
Contract liabilities (Note b)
Deferred transition revenue	$	131,108	$	116,358
Advance from customers	$	44,818	$	82,175

(a)	Included in "prepaid expenses and other current assets" and "other assets" in the consolidated balance sheet.

(b)	Included in "accrued expenses and other current liabilities" and "other liabilities" in the consolidated balance sheet.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

20. Net revenues (Continued)

Contract assets represent the contract acquisition fees or other upfront fees paid to a customer. Such costs are amortized over the expected period of benefit and recorded as an adjustment to the transaction price and deducted from revenue. The Company’s assessment did not indicate any significant impairment losses on its contract assets for the periods presented.

Contract liabilities include that portion of revenue for which payments have been received in advance from customers. The Company also defers revenues attributable to certain process transition activities for which costs have been capitalized by the Company as contract fulfillment costs. Consideration received from customers, if any, relating to such transition activities is also included as part of contract liabilities. The contract liabilities are included within “Accrued expenses and other current liabilities” and “Other liabilities” in the unaudited consolidated balance sheets. The revenues are recognized as (or when) the performance obligation is fulfilled under the contract with the customer.

Changes in the Company’s contract asset and liability balances during the three and nine months ended September 30, 2019 and 2020 were a result of normal business activity and not materially impacted by any other factors.

Revenue recognized during the three months ended September 30, 2019 and 2020 that was included in the contract liabilities balance at the beginning of the period was $36,257 and $51,201, respectively. Revenue recognized during the nine months ended September 30, 2019 and 2020 that was included in the contract liabilities balance at the beginning of the period was $83,114 and $83,189, respectively.

The following table includes estimated revenue expected to be recognized in the future related to remaining performance obligations as of September 30, 2020:

Particulars		Total				Less than 1 year						1-3 years											3-5 years											After 5 years
Transaction price allocated to remaining performance obligations		$	198,533			$	132,754					$	52,360									$		11,264									$ 2,155

The following table provides details of the Company’s contract cost assets:

	Three months ended September 30,								Nine months ended September 30,
	2019				2020				2019				2020
Particulars	Sales incentive programs		Transition activities		Sales incentive programs		Transition activities		Sales incentive programs		Transition activities		Sales incentive programs		Transition activities
Opening balance	$	35,593	$	156,585	$	32,182	$	178,570	$	25,891	$	134,302	$	35,366	$ 170,132
Closing balance		35,146		171,357		30,047		181,747		35,146		171,357		30,047	181,747
Amortization		4,496		15,106		6,094		17,935		13,044		41,701		14,329	50,397

21. Other operating (income) expense, net

	Three months ended September 30,					Nine months ended September 30,
	2019		2020			2019			2020
Write-down of intangible assets and property, plant and equipment*	$	—	$	674		$	3,511		$	10,647
Write-down of operating right-of-use assets and other assets*		—		—			—			10,244
Other operating (income) expense		59		(4,192	)		(3,421	)		(5,900	)
Other operating (income) expense, net	$	59	$	(3,518	)	$	90		$	14,991

*See note 27 for additional information about other operating (income) expense, net for the nine months ended September 30, 2020.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

22. Interest income (expense), net

	Three months ended September 30,						Nine months ended September 30,
	2019			2020			2019			2020
Interest income	$	1,968		$	1,828		$	4,758		$	5,229
Interest expense		(12,189	)		(14,585	)		(38,245	)		(43,301	)
Interest income (expense), net	$	(10,221	)	$	(12,757	)	$	(33,487	)	$	(38,072	)

23. Income taxes

The Company determines its tax provision for interim periods using an estimate of its annual effective tax rate adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if its estimated tax rate changes, the Company makes a cumulative adjustment.

As of December 31, 2019, the Company had unrecognized tax benefits amounting to $31,029, including an amount of $29,835, which, if recognized, would impact the Company’s effective tax rate, or ETR.

The following table summarizes activities related to the Company’s unrecognized tax benefits for uncertain tax positions for the nine months ended September 30, 2020:

	2020
Opening balance at January 1	$	31,029
Decrease related to prior year tax positions		(37	)
Decrease related to prior year tax position due to lapse of applicable statute of limitation		(912	)
Increase related to current year tax positions		271
Decrease related to settlements with tax authorities		(310	)
Effect of exchange rate changes		(582	)
Closing balance at September 30	$	29,459

The Company’s unrecognized tax benefits as of September 30, 2020 include an amount of $28,265, which, if recognized, would impact the Company’s ETR. As of December 31, 2019 and September 30, 2020, the Company had accrued approximately $5,812 and $6,174, respectively, in interest relating to unrecognized tax benefits.

During the year ended December 31, 2019 and the nine months ended September 30, 2020, the Company recognized approximately $826 and $525, respectively, excluding the impact of exchange rate differences, in interest on unrecognized tax benefits. As of December 31, 2019 and September 30, 2020, the Company had accrued approximately $1,084 and $1,005, respectively, for penalties.

24. Related party transactions

The Company has from time to time entered into related party transactions with non-consolidating affiliates and Bain Capital Investors, LLC (“Bain”), which was an affiliate of significant shareholders of the Company until November 2019. During the year ended December 31, 2019, Bain’s affiliates sold their remaining shares in the Company and Bain is no longer a related party, and the Company also has sold its investments in non-consolidating affiliates. Accordingly, transactions between the Company, its non-consolidating affiliates, and Bain are no longer presented as related party transactions for the nine months ended September 30, 2020. The value of related party transactions entered into during the nine months ended September 30, 2019 was not significant.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

25. Other income (expense), net

	Three months ended September 30,				Nine months ended September 30,
	2019		2020		2019		2020
Government incentives	$	—	$	—	$	3,976	$	—
Other income (expense)		704		960		1,091		946
Other income (expense), net	$	704	$	960	$	5,067	$	946

26. Commitments and contingencies

Capital commitments

As of December 31, 2019 and September 30, 2020, the Company has committed to spend $5,368 and $9,780, respectively, under agreements to purchase property, plant and equipment. This amount is net of capital advances paid in respect of these purchases.

Bank guarantees

The Company has outstanding bank guarantees and letters of credit amounting to $9,585 and $8,830 as of December 31, 2019 and September 30, 2020, respectively. Bank guarantees are generally provided to government agencies and excise and customs authorities for the purpose of maintaining a bonded warehouse. These guarantees may be revoked if the government agencies suffer any losses or damages through the breach of any of the covenants contained in the agreements governing such guarantees.

Other commitments

Certain units of our Indian subsidiaries are established as Software Technology Parks of India units or Special Economic Zone (“SEZ”) units under the relevant regulations issued by the Government of India. These units are exempt from customs and other duties on imported and indigenous capital goods, stores and spares. SEZ units are also exempt from the goods and services tax that was introduced in India in 2017. The Company has undertaken to pay taxes and duties, if any, in respect of capital goods, stores, spares and services consumed duty-free, in the event that certain terms and conditions are not fulfilled.

Contingency

In February 2019, there was a judicial pronouncement in India with respect to defined contribution benefit payments interpreting certain statutory defined contribution obligations of employees and employers. It is not currently clear whether the interpretation set out in the pronouncement has retrospective application. If applied retrospectively, the interpretation would result in an increase in contributions payable by the Company for past periods for certain of its India-based employees. There are numerous interpretative challenges concerning the retrospective application of the judgment. Due to such challenges and a lack of interpretive guidance, and based on legal advice the Company has obtained on the matter, it is currently impracticable to reliably estimate the timing and amount of any payments the Company may be required to make. Accordingly, the Company plans to obtain further clarity and will evaluate the amount of a potential provision, if any.

In the second quarter of 2020, a first appellate authority ruled in favor of Indian taxing authorities who had denied a $3,569 Goods and Services Tax (“GST”) refund the Company had claimed. The Company had requested the refund pursuant to the tax exemption available for exports under the GST regime in respect of services performed by the Company in India for affiliates and clients outside of India. In denying the refund, the taxing authorities have taken the position that the services provided are local services, which interpretation, if correct, would make the GST exemption on exports unavailable to the Company in respect of such services. The Company believes that the denial of the GST exemption is incorrect and that the risk that the liability will materialize is remote. Accordingly, no reserve has been provided as of September 30, 2020.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

26. Commitments and contingencies (Continued)

In September 2020, the Indian Parliament approved the Code on Social Security, 2020 (the “Code”), which will impact the Company’s contributions to its defined contribution and defined benefit plans for employees based in India. The date the changes will take effect is not yet known and the rules for quantifying the financial impact have not yet been published. The Company will evaluate the impact of the Code on the Company in the financial statements for the period in which the Code becomes effective and the related rules are published.

27. Restructuring

In the second quarter of 2020, due to the impact of the COVID-19 pandemic on the Company’s current and expected future revenues, the Company recorded a $21,658 restructuring charge primarily relating to the abandonment of leased office premises and employee severance charges. In the third quarter of 2020, the Company recorded an additional charge of $4,889 relating to employee severance charges.

Of the total recorded restructuring charges of $26,547 for the second and third quarters of 2020, $11,152 was a non-cash charge (including $908 related to writing down certain property, plant and equipment) recorded as other operating expense, which pertains to the abandonment of various leased office premises as a result of the Company’s consolidation of underutilized office premises due to lower demand or shifting to a work-from-home model. The Company made efforts to sublease certain office premises instead of abandoning them, but due to the COVID-19 pandemic and the related widespread adoption of work-from-home practices by many businesses worldwide, the Company was unable to sublease such premises, and it is unlikely that the Company will be able to sublease any such premises in the foreseeable future. The Company also recorded a severance charge of $15,394 in personnel expense as a result of a focused reduction in its workforce. There are no further restructuring costs expected related to this restructuring plan.

28. Subsequent Events

Acquisition

On October 5, 2020, the Company acquired all of the outstanding equity interests in SomethingDigital.Com LLC (“Something Digital”), a New York limited liability company. Something Digital specializes in ecommerce website design, digital strategy and user experience. The acquisition of Something Digital expands the Company’s existing experience business.

Share Repurchase

Pursuant to its share repurchase program, the Company repurchased 1,105,000 of its common shares on the open market between October 1, 2020 and October 27, 2020 at a weighted average price of $38.41 per share for an aggregate cash amount of $42,448.

Dividend

On October 21, 2020, the Company announced that its Board of Directors has declared a dividend for the fourth quarter of 2020 of $0.0975 per common share, which is payable on December 23, 2020 to shareholders of record as of the close of business on December 9, 2020. The declaration of any future dividends will be at the discretion of the Board of Directors.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with our consolidated financial statements and the related notes that appear elsewhere in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2019 and with the information under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2019. In addition to historical information, this discussion includes forward-looking statements and information that involves risks, uncertainties and assumptions, including but not limited to those listed below and under “Risk Factors” in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020, and in our Annual Report on Form 10-K for the year ended December 31, 2019.

Special Note Regarding Forward-Looking Statements

We have made statements in this Quarterly Report on Form 10-Q (the “Quarterly Report”) in, among other sections, Part I, Item 2—“Management’s Discussion and Analysis of Financial Condition and Results of Operations” that are forward-looking statements. In some cases, you can identify these statements by forward-looking terms such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate,” “could,” “may,” “shall,” “will,” “would” and variations of such words and similar expressions, or the negative of such words or similar expressions. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, which in some cases may be based on our growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from those expressed or implied by the forward-looking statements. In particular, you should consider the numerous risks outlined in Part II, Item 1A—“Risk Factors” in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020, and Part I, Item 1A—“Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019. For a discussion of risks of which we are aware in relation to the novel coronavirus (“COVID-19”) pandemic, see “The ongoing coronavirus (COVID-19) pandemic has adversely impacted our business and results of operations. The ultimate impact of COVID-19 on our business, financial condition and results of operations will depend on future developments which are highly uncertain and cannot be predicted at this time, including the scope and duration of the pandemic and actions taken by governmental authorities and our clients in response to the pandemic” under Part II, Item 1A—“Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020. Many of the risks, uncertainties and other factors identified below are, and will be, amplified by the COVID-19 pandemic.

Forward-looking statements we may make include, but are not limited to, statements relating to:

•

our ability to retain existing clients and contracts;

•

our ability to win new clients and engagements;

•

the expected value of the statements of work under our master service agreements;

•

our beliefs about future trends in our market;

•

political, economic or business conditions in countries where we have operations or where our clients operate, including the uncertainty related to the withdrawal of the United Kingdom from the European Union, commonly known as Brexit, and heightened economic and political uncertainty within and among other European Union member states;

•

expected spending on business process outsourcing and information technology services by clients;

•

foreign currency exchange rates;

•

our ability to convert bookings to revenue;

•

our rate of employee attrition;

•

our effective tax rate; and

•

competition in our industry.

Factors that may cause actual results to differ from expected results include, among others:

•

the impact of the COVID-19 pandemic and related response measures on our business, results of operations and financial condition, including the impact of governmental lockdowns and other restrictions on our operations and processes and those of our clients and suppliers;

•

our ability to develop and successfully execute our business strategies;

•

our ability to grow our business and effectively manage growth and international operations while maintaining effective internal controls;

•

our ability to comply with data protection laws and regulations and to maintain the security and confidentiality of personal and other sensitive data of our clients, employees or others;

•

telecommunications or technology disruptions or breaches, natural or other disasters, or medical epidemics or pandemics, including the COVID-19 pandemic;

•

our dependence on favorable policies and tax laws that may be changed or amended in a manner adverse to us or be unavailable to us in the future, including as a result of the 2017 tax legislation in the United States or tax policy changes in India, and our ability to effectively execute our tax planning strategies;

•

our dependence on revenues derived from clients in the United States and Europe and clients that operate in certain industries, such as the financial services industry;

•

our ability to successfully consummate or integrate strategic acquisitions;

•

our ability to maintain pricing and employee utilization rates;

•

our ability to maintain pricing and asset utilization rates;

•

our ability to hire and retain enough qualified employees to support our operations;

•

increases in wages in locations in which we have operations;

•

our ability to service our defined contribution and benefit plans payment obligations;

•

clarification as to the possible retrospective application of a judicial pronouncement in India regarding our defined contribution and benefit plans payment obligations;

•

our relative dependence on the General Electric Company (GE) and our ability to maintain our relationships with divested GE businesses;

•

financing terms, including, but not limited to, changes in the London Interbank Offered rate, or LIBOR, including the pending global phase-out of LIBOR, and changes to our credit ratings;

•

our ability to meet our corporate funding needs, pay dividends and service debt, including our ability to comply with the restrictions that apply to our indebtedness that may limit our business activities and investment opportunities;

•

restrictions on visas for our employees traveling to North America and Europe;

•

fluctuations in currency exchange rates between the currencies in which we transact business, primarily the U.S. dollar, Australian dollar, Chinese renminbi, Euro, Indian rupee, Japanese yen, Mexican peso, Polish zloty, Romanian leu, Hungarian forint and U.K. pound sterling;

•

our ability to retain senior management;

•

the selling cycle for our client relationships;

•

our ability to attract and retain clients and our ability to develop and maintain client relationships on attractive terms;

•

legislation in the United States or elsewhere that adversely affects the performance of business process outsourcing and information technology services offshore;

•

increasing competition in our industry;

•

our ability to protect our intellectual property and the intellectual property of others;

•

deterioration in the global economic environment and its impact on our clients, including the bankruptcy of our clients;

•

regulatory, legislative and judicial developments, including the withdrawal of governmental fiscal incentives;

•

the international nature of our business;

•

technological innovation;

•

our ability to derive revenues from new service offerings and acquisitions; and

•

unionization of any of our employees.

Although we believe the expectations reflected in the forward-looking statements are reasonable at the time they are made, we cannot guarantee future results, level of activity, performance or achievements. Achievement of future results is subject to risks, uncertainties, and potentially inaccurate assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected. You should bear this in mind as you consider forward-looking statements. We undertake no obligation to update any of these forward-looking statements after the date of this filing to conform our prior statements to actual results or revised expectations. You are advised, however, to consult any further disclosures we make on related subjects in our Form 10-K, Form 10-Q and Form 8-K reports to the Securities and Exchange Commission (the “SEC”).

Continued impact of COVID-19 on our business and results of operations

The outbreak of COVID-19 across the globe and responsive government measures have adversely impacted the global economy and the markets in which we operate since the first quarter of 2020, leading to disruptions to our business. This section provides a brief overview of how we are responding to known and anticipated impacts of the COVID-19 pandemic on our business, financial condition and results of operations. We also provide additional information about the effects of the COVID-19 pandemic on our business and results of operations in other relevant sections of this Quarterly Report on Form 10-Q.

The safety and well-being of our employees have been and will continue to be our top priorities during this global crisis, followed immediately by continuing to deliver high-quality services to our clients. The vast majority of our employees continue to work remotely. For the limited number of employees who have returned to our offices, we have implemented new safety, cleaning and medical screening procedures in our offices. We have also created a response team, which includes members of our Global Leadership Council, to coordinate and oversee our actions in response to the COVID-19 pandemic, including with respect to business continuity planning, revenue and profitability, transformation service offerings to address new and developing client needs, and human resource policies. We believe that this coordinated effort will maximize our flexibility and allow us to quickly implement necessary protocols for devising unique solutions to the problems we and our clients are facing and may face in the future in relation to the pandemic.

In addition, we took a series of actions during the second and third quarters of 2020 to address the challenges being placed on our operations by the pandemic and the potential impact to our business in the near term and to protect the long-term health of our business. For additional information, see Note 27—“Restructuring” under Part I, Item 1—“Financial Statements” above. We continue to evaluate market conditions and are taking precautionary measures to strengthen our financial position, including reevaluating the pace of our investment plans, hiring practices, investments in capital assets, use of our real estate and facilities, and discretionary spending, including marketing and travel expenses. We continued to maintain a strong liquidity position through the third quarter of 2020, ending the quarter with $803.4 million of consolidated cash and cash equivalents after partially repaying our revolving credit facility, which we had drawn down in the second quarter of 2020. Given our strengthened liquidity and the recent improvement in debt market conditions, we are likely to reduce the balance outstanding on our revolving credit facility in the fourth quarter of 2020. See “Liquidity and Capital Resources” below for further information.

Overall, the pandemic has had an adverse impact on our financial results year-to-date. Our net revenues from various service lines, including transformation services, have also been adversely impacted by market developments, including delays or cancellations of new projects and new orders. Total net revenues increased approximately 5.3% compared to the third quarter of 2019 and 3.9% compared to the second quarter of 2020, which was better than we anticipated at the beginning of the quarter. We currently anticipate that many of the impacts we experienced in the nine months ended September 30, 2020 related to demand, profitability and cash flows will continue into future periods depending on the severity and duration of the pandemic. For more information about the effects of the COVID-19 pandemic on our results of operations for the three and nine months ended September 30, 2020, see the section titled “Results of Operations” below and Note 20—“Net revenues” under Part I, Item 1—“Financial Statements” above.

As the COVID-19 pandemic evolves, we will continue to assess its impact on the Company and respond accordingly. The ultimate impact of COVID-19 on our business and the industry in which we operate remains unknown and unpredictable. Our past results may not be indicative of our future performance, and our financial results in future periods, including but not limited to net revenues, income from operations, income from operations margin, net income and earnings per share, may differ materially from historical trends. The extent of the impact of the COVID-19 pandemic on our business will depend on a number of factors, including but not limited to the duration and severity of the pandemic; advances in testing, treatment and prevention; the macroeconomic impact of government measures to contain the spread of the virus; and related government stimulus measures. We are currently unable to predict the full impact that COVID-19 will have on our results from operations, financial condition, liquidity and cash flows due to numerous uncertainties, including the duration and severity of the pandemic and containment measures and the related macroeconomic impacts. For example, to the extent the pandemic continues to disrupt economic activity globally, we, like other businesses, will not be immune from its effects, and our business, results of operations and financial condition may be adversely affected, possibly materially, by prolonged decreases in spending on the types of services we provide, deterioration of our clients’ credit, or reduced economic activities. In addition, some of our expenses are less variable in nature and do not closely correlate in revenues, which may lead to a decrease in our profitability.

We continue to actively monitor the COVID-19 situation and may take further actions that alter our business operations as may be required by any regulatory authorities or that we determine are in the best interests of our employees, customers, suppliers and shareholders.

For additional information about the risks we face in relation to the pandemic, see Part II, Item 1A—“Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020.

Overview

We are a global professional services firm that makes business transformation real. We drive digital-led innovation and run digitally-enabled intelligent operations for our clients, guided by our experience running thousands of processes for hundreds of Fortune Global 500 clients. We have over 96,300 employees serving clients in key industry verticals from more than 30 countries. Our registered office is located at Victoria Place, 5^th Floor, 31 Victoria Street, Hamilton HM 10, Bermuda.

In the quarter ended September 30, 2020, we had net revenues of $935.5 million, of which $824.2 million, or 88.1%, was from clients other than General Electric (“GE”), which we refer to as Global Clients, with the remaining $111.3 million, or 11.9%, from GE.

Certain Acquisitions

On November 12, 2019, we acquired the outstanding equity/limited liability company interests in Rightpoint Consulting, LLC, an Illinois limited liability company, and certain affiliated entities in the United States and India (collectively referred to as “Rightpoint”) for total purchase consideration of $270.7 million. This amount includes cash consideration of $268.2 million, net of cash acquired of $2.5 million. This acquisition expands our capabilities in improving customer experience and strengthens our reputation as a thought leader in this space. The securities purchase agreement provided certain of the selling equity holders the option to elect to either (a) receive 100% consideration in cash at the closing date for their limited liability company interests and vested options or (b) “roll over” and retain 25% of their Rightpoint limited liability company interests and vested options and receive consideration in cash at closing for the remaining 75% of their Rightpoint limited liability company interests and vested options. Certain selling equity holders elected to receive deferred, variable earnout consideration with an estimated value of $21.5 million over the three-year rollover period. The amount of deferred consideration ultimately paid to the rollover sellers will be based on the future revenue multiple of the acquired business and is included in the purchase consideration outstanding as of September 30, 2020. Goodwill arising from the acquisition amounting to $182.8 million has been allocated among our three reporting units as follows: Banking, Capital Markets and Insurance (“BCMI”) in the amount of $17.5 million, Consumer Goods, Retail, Life Sciences and Healthcare (“CGRLH”) in the amount of $44.4 million and High Tech, Manufacturing and Services (“HMS”) in the amount of $120.9 million, using a relative fair value allocation method. Of the total goodwill amount, $97.8 million is deductible for income tax purposes. The goodwill primarily represents the acquired capabilities, operating synergies and other benefits expected to result from combining the acquired operations with those of the Company.

On January 7, 2019, we acquired 100% of the outstanding equity interests in riskCanvas Holdings, LLC, a Delaware limited liability company, for total purchase consideration of $5.75 million. This amount includes cash consideration of $5.7 million, net of adjustment for working capital. This acquisition expands our services in the areas of financial institution fraud, anti-money laundering and financial transaction surveillance and enhances our consulting capabilities for clients in the financial services industry. Goodwill arising from the acquisition amounted to $2.6 million, which has

been allocated to our BCMI reporting unit and is deductible for income tax purposes. The goodwill primarily represents the acquired capabilities, operating synergies and other benefits expected to result from combining the acquired operations with those of the Company.

Critical Accounting Policies and Estimates

For a description of our critical accounting policies, see Note 2—“Summary of significant accounting policies” under Part I, Item 1—“Financial Statements” above, Part II, Item 7—“Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates,” and Note 2—“Summary of significant accounting policies” under Part IV, Item 15—“Exhibits and Financial Statement Schedules” in our Annual Report on Form 10-K for the year ended December 31, 2019.

We adopted the new accounting standard for current expected credit losses (Topic 326) effective January 1, 2020, using the modified retrospective transition approach. For further discussion and additional disclosure regarding our adoption of this standard, see Note 2—“Summary of significant accounting policies” and Note 5—“Accounts receivable, net of allowance for credit losses” under Part I, Item 1—“Financial Statements” above.

Due to rounding, the numbers presented in the tables included in this “Item 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations” may not add up precisely to the totals provided.

Results of Operations

The following table sets forth certain data from our consolidated statements of income for the three and nine months ended September 30, 2019 and 2020.

													Percentage Change Increase/(Decrease)
	Three months ended September 30,						Nine months ended September 30,						Three months ended September 30,			Nine months ended September 30,
	2019			2020			2019			2020			2020 vs. 2019			2020 vs. 2019
	(dollars in millions)						(dollars in millions)
Net revenues—Global Clients	$	767.7		$	824.2		$	2,231.1		$	2,409.0			7.4	%		8.0	%
Net revenues—GE		121.1			111.3			348.7			349.8			(8.0	)%		0.3	%
Total net revenues		888.8			935.5			2,579.8			2,758.8			5.3	%		6.9	%
Cost of revenue		573.7			605.8			1,664.0			1,804.5			5.6	%		8.4	%
Gross profit		315.1			329.7			915.8			954.3			4.6	%		4.2	%
Gross profit margin		35.5	%		35.2	%		35.5	%		34.6	%
Operating expenses
Selling, general and administrative expenses		194.5			198.3			582.3			582.0			2.0	%		0.0	%
Amortization of acquired intangible assets		7.0			10.2			23.6			31.7			47.1	%		34.4	%
Other operating (income) expense, net		0.1			(3.5	)		0.1			15.0		NM		*	NM		*
Income from operations		113.6			124.6			309.9			325.7			9.7	%		5.1	%
Income from operations as a percentage of net revenues		12.8	%		13.3	%		12.0	%		11.8	%
Foreign exchange gains (losses), net		6.7			(2.4	)		3.6			11.6			(135.7	)%		218.5	%
Interest income (expense), net		(10.2	)		(12.8	)		(33.5	)		(38.1	)		24.8	%		13.7	%
Other income (expense), net		0.7			1.0			5.1			0.9			36.4	%		(81.3	)%
Income before equity-method investment activity, net and income tax expense		110.8			110.4			285.1			300.1			(0.3	)%		5.3	%
Equity-method investment activity, net		—			—			—			—		—		%	—		%
Income before income tax expense		110.8			110.4			285.1			300.1			(0.3	)%		5.3	%
Income tax expense		22.7			25.0			62.4			66.9			10.3	%		7.2	%
Net income		88.1			85.4			222.7			233.3			(3.0	)%		4.8	%
Net income as a percentage of net revenues		9.9	%		9.1	%		8.6	%		8.5	%

*N0t Meaningful

Three Months Ended September 30, 2020 Compared to the Three Months Ended September 30, 2019

Net revenues. Our net revenues were $935.5 million in the third quarter of 2020, up $46.7 million, or 5.3%, from $888.8 million in the third quarter of 2019. The growth in our net revenues was primarily driven by increases in both transformation services and intelligent operations delivered to Global Clients, primarily in our CGRLH segment, high tech clients within our HMS segment and insurance clients within our BCMI segment. Our net revenues from GE declined in the third quarter of 2020 compared to the third quarter of 2019, mainly due to committed productivity and a reduction in GE’s discretionary expenditures on IT and other shorter cycle projects resulting from the uncertain macro environment caused by the COVID-19 pandemic.

Adjusted for foreign exchange, primarily the impact of changes in the value of the Australian dollar, Indian rupee, euro and U.K. pound sterling against the U.S. dollar, our net revenues grew 5.4% in the third quarter of 2020 compared to the third quarter of 2019 on a constant currency basis. Revenue growth on a constant currency basis is a non-GAAP measure. We provide information about our revenue growth on a constant currency basis so that our revenue may be viewed without the impact of foreign currency exchange rate fluctuations, thereby facilitating period-to-period comparisons of our business performance. Total net revenues on a constant currency basis are calculated by restating current-period activity using the prior fiscal period’s foreign currency exchange rates and adjusted for hedging gains/losses.

Our average headcount increased by 4.1% to approximately 96,700 in the third quarter of 2020 from approximately 92,900 in the third quarter of 2019.

					Percentage Change
	Three months ended September 30,				Increase/(Decrease)
	2019		2020		2020 vs. 2019
	(dollars in millions)
Net revenues – Global Clients	$	767.7	$	824.2		7.4	%
Net revenues – GE	$	121.1	$	111.3		(8.0)	%
Total net revenues	$	888.8	$	935.5		5.3	%

Net revenues from Global Clients in the third quarter of 2020 were $824.2 million, up $56.5 million, or 7.4%, from $767.7 million in the third quarter of 2019. This increase was primarily driven by growth in our CGRLH segment, high tech clients within our HMS segment and insurance clients within our BCMI segment. As a percentage of total net revenues, net revenues from Global Clients increased from 86.4% in the third quarter of 2019 to 88.1% in the third quarter of 2020.

Net revenues from GE in the third quarter of 2020 declined 8.0% compared to the third quarter of 2019, mainly due to committed productivity and a reduction in GE’s discretionary expenditures on IT and other shorter cycle projects resulting from the uncertain macro environment caused by the COVID-19 pandemic.

Revenues by segment were as follows:

							Percentage Change
	Three months ended September 30,						Increase /(Decrease)
	2019			2020			2020 vs. 2019
	(dollars in millions)
BCMI		282.2			283.8			0.6	%
CGRLH	$	273.1		$	318.3			16.6	%
HMS		338.2			339.0			0.2	%
Others		(4.6	)		(5.6	)		(21.1)	%
Total net revenues	$	888.8		$	935.5			5.3	%

Net revenues from our BCMI segment were largely flat in the third quarter of 2020 compared to the third quarter of 2019, as higher revenues from clients in our insurance vertical were partially offset by slightly lower revenues from clients in our banking and capital markets vertical. Net revenues from our CGRLH segment increased by 16.6% in the third quarter of 2020 compared to the third quarter of 2019, primarily driven by an increase in transformation services, which

also included revenue from Rightpoint which was acquired in the fourth quarter of 2019. Net revenues from our HMS segment were flat in the third quarter of 2020 compared to the third quarter of 2019. An increase in revenues from clients in our high tech vertical was partially offset by lower revenues from clients in our manufacturing and services vertical, including GE, who were adversely impacted by COVID-19. Net revenues from Others primarily represents the impact of foreign exchange fluctuations, which is not allocated to the Company’s segments for management’s internal reporting purposes. For additional information, see Note 19—“Segment reporting” under Part I, Item 1—“Financial Statements” above.

Cost of revenue. Cost of revenue was $605.8 million in the third quarter of 2020, up $32.2 million, or 5.6%, from the third quarter of 2019. The increase in our cost of revenue in the third quarter of 2020 compared to the third quarter of 2019 was primarily due to (i) an increase in our operational headcount, including in the number of onshore personnel related to large new deals and transformation services delivery as well as from the acquisition of Rightpoint, (ii) wage inflation, (iii) a non-recurring employee severance charge as part of our COVID-19 related restructuring plan, (iv) a non-recurring charge related to retirement fund assets in India, and (v) an increase in depreciation expense due to the expansion of certain existing facilities and the purchase/deployment of new assets, including technology-related intangible assets, and finance leases entered into after the third quarter of 2019. This increase was partially offset by (i) improved utilization of transformation services resources and (ii) lower discretionary spending following the onset of the COVID-19 pandemic, in the third quarter of 2020 compared to the third quarter of 2019. For additional information, see Note 27—“Restructuring” under Part I, Item 1—“Financial Statements” above.

Gross margin. Our gross margin decreased from 35.5% in the third quarter of 2019 to 35.2% in the third quarter of 2020, driven primarily by a non-recurring employee severance charge related to our COVID-19 related restructuring plan and a non-recurring charge related to retirement fund assets in India.

Selling, general and administrative expenses (SG&A). SG&A expenses as a percentage of total net revenues decreased from 21.9% in the third quarter of 2019 to 21.2% in the third quarter of 2020. SG&A expenses were $198.3 million in the third quarter of 2020, up $3.8 million, or 2.0%, from the third quarter of 2019. This increase in expense was primarily due to (i) a non-recurring employee severance charge as part of our restructuring and (ii) wage inflation. This increase was partially offset by lower discretionary spending and travel costs due to the COVID-19 pandemic in the third quarter of 2020 compared to the third quarter of 2019.

Amortization of acquired intangibles. Non-cash charges related to the amortization of acquired intangibles were $10.2 million in the third quarter of 2020, up $3.3 million, or 47.1%, from the third quarter of 2019. This increase is primarily due to higher amortization related to intangibles acquired after the third quarter of 2019 primarily related to the acquisition of Rightpoint in the fourth quarter of 2019, partially offset by the completion of the useful lives of intangibles acquired in prior periods in the third quarter of 2020.

Other operating (income) expense, net. Other operating income (net of expense) increased by $3.6 million in the third quarter of 2020 compared to the third quarter of 2019. The increase is primarily due to a change in the fair value of an earn-out liability of $3.8 million that was recognized in the third quarter of 2020 compared to the third quarter of 2019.

Income from operations. As a result of the foregoing factors, income from operations as a percentage of total net revenues increased from 12.8% in the third quarter of 2019 to 13.3% in the third quarter of 2020. Income from operations increased by $11.1 million to $124.6 million in the third quarter of 2020 from $113.6 million in the third quarter of 2019 driven by higher revenues and associated operating income margins.

Foreign exchange gains (losses), net. We recorded a net foreign exchange loss of $2.4 million in the third quarter of 2020, compared to a net foreign exchange gain of $6.7 million in the third quarter of 2019. The loss in the third quarter of 2020 was due to the appreciation of Hungarian forint and Philippine peso against the U.S. dollar, and the gain in the third quarter of 2019 resulted primarily from the depreciation of the Indian rupee against the U.S. dollar.

Interest income (expense), net. Our interest expense (net of interest income) was $12.8 million in the third quarter of 2020, up $2.5 million, or 24.8%, from the third quarter of 2019, primarily due to a $2.4 million increase in interest expense and a $0.1 million decrease in interest income. The increase in interest expense was primarily due to interest expense on our $400 million aggregate principal amount of 3.375% senior notes issued in November 2019 (the “2019 Senior Notes”). This increase was partially offset by a lower average London Interbank Offered Rate (“LIBOR”)-based rate on our revolving credit facility and our term loan due to a decrease in the average LIBOR rate during the third quarter of 2020 compared to the third quarter of 2019, reduced by lower gains on interest rate swaps in the third quarter of 2020 compared to the third quarter of 2019, which we discuss in the section titled “Liquidity and Capital Resources—Financial

Condition” below. The weighted average rate of interest on our debt, including the net impact of interest rate swaps, decreased from 3.2% in the third quarter of 2019 to 2.9% in the third quarter of 2020.

Other income (expense), net. Our other income (net of expense) was $1.0 million in the third quarter of 2020 compared to $0.7 million in the third quarter of 2019. The increase was primarily due to a gain on the fair value of the assets in our deferred compensation plan in the third quarter of 2020 compared to the third quarter of 2019, partially offset by a marked-to-market gain on investments held for sale recorded in the third quarter of 2019, for which there was no corresponding gain in the third quarter of 2020.

Income tax expense. Our income tax expense was $25.0 million in the third quarter of 2020, up from $22.7 million in the third quarter of 2019, representing an effective tax rate (“ETR”) of 22.6%, up from 20.5% in the third quarter of 2019. The increase in our effective tax rate is primarily due to a change in the jurisdictional mix of our income and the absence in the third quarter of 2020 of certain employment-related tax benefits in India that we recorded in the third quarter of 2019, partially offset by certain discrete benefits recorded in the third quarter of 2020.

Net income. As a result of the foregoing factors, net income as a percentage of total net revenues was 9.1% in the third quarter of 2020, down from 9.9% in the third quarter of 2019. Net income decreased $2.7 million from $88.1 million in the third quarter of 2019 to $85.4 million in the third quarter of 2020.

Adjusted income from operations. Adjusted income from operations (“AOI”) increased by $17.7 million from $142.3 million in the third quarter of 2019 to $160.0 million in the third quarter of 2020. Our AOI margin increased from 16.0% in the third quarter of 2019 to 17.1% in the third quarter of 2020 due to an increase in revenues in the third quarter of 2020 compared to the third quarter of 2019 coupled with improved operating leverage and cost containment initiatives undertaken in the third quarter of 2020. These initiatives included lower discretionary spending and targeted reductions in our workforce, including in our transformation services, to improve utilization levels and align overall SG&A spending with revised revenue expectations in the context of the COVID-19 pandemic.

AOI is a non-GAAP measure and is not based on any comprehensive set of accounting rules or principles and should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. We believe that presenting AOI together with our reported results can provide useful supplemental information to our investors and management regarding financial and business trends relating to our financial condition and results of operations. A limitation of using AOI versus net income calculated in accordance with GAAP is that AOI excludes certain recurring costs and certain other charges, namely stock-based compensation and amortization of acquired intangibles. We compensate for this limitation by providing specific information on the GAAP amounts excluded from AOI.

We calculate AOI as net income, excluding (i) stock-based compensation, (ii) amortization and impairment of acquired intangible assets, (iii) acquisition-related expenses excluded in the period in which an acquisition is consummated, (iv) foreign exchange (gain)/loss, (v) restructuring expenses, (vi) interest (income) expense, and (vii) income tax expense, as we believe that our results after taking into account these adjustments more accurately reflect our ongoing operations. For additional information, see Note 19—“Segment reporting” under Part I, Item 1—“Financial Statements” above.

During the second and third quarters of 2020, as a result of the COVID-19 pandemic, the Company undertook restructuring measures that resulted in a charge of $4.9 million in the third quarter of 2020. This charge has been excluded from AOI in the third quarter of 2020. For additional information, see Note 27—“Restructuring” under Part I, Item 1—“Financial Statements” above.

The following table shows the reconciliation of AOI to net income, the most directly comparable GAAP measure for the three months ended September 30, 2019 and 2020:

	Three months ended September 30,
	2019			2020
	(dollars in millions)
Net income	$	88.1		$	85.4
Foreign exchange (gains) losses, net		(6.7	)		2.4
Interest (income) expense, net		10.2			12.8
Income tax expense		22.7			25.0
Stock-based compensation		21.3			19.5
Amortization and impairment of acquired intangible assets		6.7			10.0
Restructuring expenses		—			4.9
Adjusted income from operations	$	142.3		$	160.0

The following table sets forth our AOI by segment for the three months ended September 30, 2019 and 2020:

		Three months ended September 30,
		2019			2020
		(dollars in millions)
BCMI		$	32.7		$	38.8
CGRLH			42.7			47.8
HMS	58.5			61.0
Others			8.4			12.4

AOI of our BCMI segment increased to $38.8 million in the third quarter of 2020 from $32.7 million in the third quarter of 2019, primarily driven by more efficient utilization of transformation resources on slightly higher revenue. AOI of our CGRLH segment increased to $47.8 million in the third quarter of 2020 from $42.7 million in the third quarter of 2019, primarily due to revenue growth, higher utilization of transformation resources and operating leverage. AOI of our HMS segment increased to $61.0 million in the third quarter of 2020 from $58.5 million in the third quarter of 2019, primarily due to higher utilization of resources in the third quarter of 2020 compared to the third quarter of 2019 on slightly higher revenue. AOI for “Others” in the table above primarily represents the impact of foreign exchange fluctuations, adjustment of allowances for credit losses and over-absorption of overhead in the third quarter of 2020, as well as the impact of foreign exchange fluctuations and over-absorption of overhead in the third quarter of 2019, none of which are allocated to any individual segment for management’s internal reporting purposes. See Note 19—“Segment reporting” to our consolidated financial statements under Part I, Item 1— “Financial Statements” above.

Nine Months Ended September 30, 2020 Compared to the Nine Months Ended September 30, 2019

Net revenues. Our net revenues were $2,758.8 million in the nine months ended September 30, 2020, up $179.0 million, or 6.9%, from $2,579.8 million in the nine months ended September 30, 2019. The growth in our net revenues was from Global Clients and derived from both transformation services and intelligent operations across all of our segments. The impact of the COVID-19 pandemic on our net revenues in the nine months ended September 30, 2020 was primarily related to clients adapting to the shift in our delivery capabilities from a physical to a virtual, work-from-home operating environment as well as economic uncertainty impacted by market developments causing delays or cancellations of new projects and new orders, which impacted growth. Our BCMI segment was affected more than our other segments, most notably in the second quarter, as not all clients in this segment consented to work-from-home service delivery of processes managing highly sensitive customer information in that quarter. We anticipate that the impact of the COVID-19 pandemic in the nine months ended September 30, 2020 related to client demand is likely to continue into future periods, and may have an adverse effect on our net revenues in future periods.

Adjusted for foreign exchange, primarily the impact of changes in the value of the euro, Australian dollar, Indian rupee and U.K. pound sterling against the U.S. dollar, our net revenues grew 7.5% in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019 on a constant currency basis. Revenue growth on a constant currency basis is a non-GAAP measure. We provide information about our revenue growth on a constant currency basis so that our revenue may be viewed without the impact of foreign currency exchange rate fluctuations, thereby facilitating period-to-period comparisons of our business performance. Total net revenues on a constant currency basis are calculated by restating current-period activity using the prior fiscal period’s foreign currency exchange rates and adjusted for hedging gains/losses.

Our average headcount increased by 7.9% to approximately 97,000 in the nine months ended September 30, 2020 from approximately 90,000 in the nine months ended September 30, 2019.

					Percentage Change
	Nine months ended September 30,				Increase/(Decrease)
	2019		2020		2020 vs. 2019
	(dollars in millions)
Net revenues – Global Clients	$	2,231.1	$	2,409.0		8.0	%
Net revenues – GE	$	348.7	$	349.8		0.3	%
Total net revenues	$	2,579.8	$	2,758.8		6.9	%

Net revenues from Global Clients in the nine months ended September 30, 2020 were $2,409.0 million, up $178.0 million, or 8.0%, from $2,231.1 million in the nine months ended September 30, 2019. This increase was primarily driven by growth in our CGRLH and HMS segments. As a percentage of total net revenues, net revenues from Global Clients increased from 86.5% in the nine months ended September 30, 2019 to 87.3% in the nine months ended September 30, 2020.

Net revenues from GE were flat in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019. The minor increase in revenue from GE in the nine months ended September 30, 2020 was driven by services delivered primarily in connection with incremental work awarded in the second half of 2019, partially offset by committed productivity and a reduction in GE’s discretionary expenditures on IT and other shorter cycle projects resulting from the uncertain macro environment caused by the COVID-19 pandemic in the nine months ended September 30, 2020.

Revenues by segment were as follows:

							Percentage Change
	Nine months ended September 30,						Increase/(Decrease)
	2019			2020			2020 vs.2019
	(dollars in millions)
BCMI	$	798.2		$	805.8			1.0	%
CGRLH		802.7			930.2			15.9	%
HMS		988.7			1,045.9			5.8	%
Others		(9.8	)		(23.1	)		(135.7	)%
Total net revenues	$	2,579.8		$	2,758.8			6.9	%

Net revenues from our BCMI segment increased 1.0% in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019, primarily due to an increase in revenue associated with the continued ramp-up of large new deals, largely offset by a decrease in revenue due to delayed approvals from clients to shift to a virtual operating environment. Net revenues from our CGRLH segment increased by 15.9% in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019, primarily driven by an increase in transformation services revenues, including revenue from Rightpoint, which we acquired in the fourth quarter of 2019. Net revenues from our HMS segment increased by 5.8% in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019, primarily driven by an increase in transformation services, including revenue from Rightpoint. Net revenues from “Others” primarily represents the impact of foreign exchange fluctuations, which is not allocated to the Company’s segments for management’s internal reporting purposes. For additional information, see Note 19—“Segment reporting” under Part I, Item 1—“Financial Statements” above.

Cost of revenue. Cost of revenue was $1,804.5 million in the nine months ended September 30, 2020, up $140.5 million, or 8.4%, from the nine months ended September 30, 2019. The increase in our cost of revenue in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019 was primarily due to (i) an increase in our operational headcount, including in the number of onshore personnel, related to large new deals and transformation services delivery as well as from the acquisition of Rightpoint, (ii) wage inflation, (iii) a non-recurring employee severance charge related to our COVID-19 related restructuring plan, (iv) a non-recurring charge related to retirement fund assets in India, and (v) an increase in depreciation expense due to the expansion of certain existing facilities and the purchase/deployment of new assets, including technology-related intangible assets, and finance leases entered into after the nine months ended September 30, 2019. This increase was partially offset by (i) improved utilization of transformation services resources and (ii) lower discretionary spending related to actions the Company took in response to the impact of the COVID-19 pandemic on our business in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019. For additional information see Note 27—“Restructuring” under Part I, Item 1—“Financial Statements” above.

Gross margin. Our gross margin decreased from 35.5% in the nine months ended September 30, 2019 to 34.6% in the nine months ended September 30, 2020, driven primarily by the impact of the COVID-19 pandemic resulting in lower utilization of intelligent operations resources due to a lack of some client consents, primarily in our BCMI segment, for our employees to work from home, a non-recurring charge related to retirement fund assets in India, and a non-recurring restructuring charge related to employee severance, partially offset by improved operating leverage.

Selling, general and administrative expenses (SG&A). SG&A expenses as a percentage of total net revenues decreased from 22.6% in the nine months ended September 30, 2019 to 21.1% in the nine months ended September 30, 2020. SG&A expenses were $582.0 million in the nine months ended September 30, 2020, down $0.3 million compared to the nine months ended September 30, 2019. This decrease in expense was primarily due to lower marketing expenses and lower travel costs due to a significant reduction in travel following the onset of the COVID-19 pandemic, an adjustment to allowances for credit losses due to the collection of aged receivables, and efficient functional spending in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019, partially offset by wage inflation after September 30, 2019.

Amortization of acquired intangibles. Non-cash charges related to the amortization of acquired intangibles were $31.7 million in the nine months ended September 30, 2020, up $8.1 million, or 34.4%, from the nine months ended September 30, 2019. This increase is primarily due to higher amortization related to intangibles acquired after September 30, 2019 primarily related to the acquisition of Rightpoint in the fourth quarter of 2019, partially offset by the completion of the useful lives of intangibles acquired in prior periods in the nine months ended September 30, 2020.

Other operating (income) expense, net. Other operating expense (net of income) increased by $14.9 million in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019. The increase is primarily due to a non-recurring impairment charge of $10.2 million related to the abandonment of various office premises as part of a restructuring and an impairment charge of $10.0 million related to tangible and intangible assets, primarily technology- and customer-related, partially offset by a $4.3 million decrease in the fair value of earn-out liabilities in the nine months ended September 30, 2020. In the nine months ended September 30, 2019, we recorded a gain of $3.4 million related to the sale of a parcel of land in India, which was largely offset by an impairment charge of $3.5 million relating to certain computer software and technology-related intangible assets. For additional information, see Note 10—“Goodwill and intangible assets” and Note 27—“Restructuring” under Part I, Item 1—“Financial Statements” above.

Income from operations. As a result of the foregoing factors, income from operations as a percentage of total net revenues decreased from 12.0% in the nine months ended September 30, 2019 to 11.8% in the nine months ended

September 30, 2020. Income from operations increased by $15.8 million to $325.7 million in the nine months ended September 30, 2020 from $309.9 million in the nine months ended September 30, 2019 driven by higher revenues.

Foreign exchange gains (losses), net. We recorded a net foreign exchange gain of $11.6 million in the nine months ended September 30, 2020, compared to a net foreign exchange gain of $3.6 million in the nine months ended September 30, 2019. The gain in the nine months ended September 30, 2020 resulted primarily from the depreciation of the Indian rupee and Australian dollar against the U.S. dollar, while the gain in the nine months ended September 30, 2019 resulted primarily from the depreciation of the Indian rupee against the U.S. dollar.

Interest income (expense), net. Our interest expense (net of interest income) was $38.1 million in the nine months ended September 30, 2020, up $4.6 million, or 13.7%, from the nine months ended September 30, 2019, primarily due to a $5.1 million increase in interest expense, partially offset by a $0.5 million increase in interest income. The increase in interest expense was due to interest expense on our $400 million aggregate principal amount of 3.375% senior notes issued in November 2019 (the “2019 Senior Notes”). This increase was partially offset by a lower average London Interbank Offered Rate (“LIBOR”)-based rate on our revolving credit facility and term loan due to a decrease in the average LIBOR rate during the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019, reduced by lower gains on interest rate swaps in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019, which we discuss in the section titled “Liquidity and Capital Resources—Financial Condition” below. Our interest income increased by $0.5 million in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019, primarily due to higher account balances in India. The weighted average rate of interest on our debt, including the net impact of interest rate swaps, decreased from 3.4% in the nine months ended September 30, 2019 to 2.9% in the nine months ended September 30, 2020.

Other income (expense), net. Our other income (net of expense) was $0.9 million in the nine months ended September 30, 2020 compared to other income (net of expense) of $5.1 million in the nine months ended September 30, 2019. In the nine months ended September 30, 2019, we recognized $4.0 million of export subsidy income in India, while no such subsidy income was recognized in nine months ended September 30, 2020. The export subsidy was introduced under the Foreign Trade Policy of India to encourage the export of specified services from India and was available for eligible export services through March 31, 2019.

Income tax expense. Our income tax expense was $66.9 million in the nine months ended September 30, 2020, up from $62.4 million in the nine months ended September 30, 2019, representing an effective tax rate (“ETR”) of 22.3%, up from 21.9% in the nine months ended September 30, 2019. The increase in our ETR is primarily due to a change in the jurisdictional mix of our income.

Net income. As a result of the foregoing factors, net income as a percentage of total net revenues was 8.5% in the nine months ended September 30, 2020, down from 8.6% in the nine months ended September 30, 2019. Net income increased by $10.6 million from $222.7 million in the nine months ended September 30, 2019 to $233.3 million in the nine months ended September 30, 2020.

Adjusted income from operations. Adjusted income from operations (“AOI”) increased by $41.3 million from $399.9 million in the nine months ended September 30, 2019 to $441.2 million in the nine months ended September 30, 2020. Our AOI margin increased from 15.5% in the nine months ended September 30, 2019 to 16.0% in the nine months ended September 30, 2020. This increase was due to an increase in revenues in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019 coupled with improved operating leverage and cost containment initiatives undertaken in the nine months ended September 30, 2020. These initiatives included lower discretionary spending and targeted reductions in our workforce, including in our transformation services, to improve utilization levels and align overall SG&A spending with revised revenue expectations in the context of the COVID-19 pandemic.

During the nine months ended September 30, 2020, as a result of the COVID-19 pandemic, the Company undertook restructuring measures that resulted in a charge of $26.5 million. This charge has been excluded from AOI in the nine months ended September 30, 2020. For additional information, see Note 27—“Restructuring” under Part I, Item 1—“Financial Statements” above.

The following table shows the reconciliation of AOI to net income, the most directly comparable GAAP measure for the nine months ended September 30, 2019 and 2020:

	Nine months ended September 30,
	2019			2020
	(dollars in millions)
Net income	$	222.7		$	233.3
Foreign exchange (gains) losses, net		(3.6	)		(11.6	)
Interest (income) expense, net		33.5			38.1
Income tax expense		62.4			66.9
Stock-based compensation		61.3			55.8
Amortization and impairment of acquired intangible assets		22.7			32.2
Acquisition-related expenses		1.0			—
Restructuring expenses		—			26.5
Adjusted income from operations	$	399.9		$	441.2

The following table sets forth our AOI by segment for the nine months ended September 30, 2019 and 2020:

		Nine months ended September 30,
		2019			2020
		(dollars in millions)
BCMI		$	88.8		$	88.9
CGRLH			115.2			134.7
HMS	175.3			178.7
Others			20.5			38.9

AOI of our BCMI segment was flat from the nine months ended September 30, 2019 to the nine months ended September 30, 2020, primarily as a result of lower revenues due to delayed work-from-home approvals from certain clients and charges related to a write-down of certain technology assets that we no longer plan to utilize or develop due to changing economic and operational conditions, in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019, partially offset by revenue growth in the segment and more efficient utilization of resources. AOI of our CGRLH segment increased to $134.7 million in the nine months ended September 30, 2020 from $115.2 million in the nine months ended September 30, 2019, primarily due to revenue growth in the segment, more efficient utilization of transformation resources and operating leverage. AOI of our HMS segment increased to $178.7 million in the nine months ended September 30, 2020 from $175.3 million in the nine months ended September 30, 2019, primarily due to incremental revenue in the nine months ended September 30, 2020. AOI for “Others” in the table above primarily represents the impact of foreign exchange fluctuations, an adjustment to allowances for credit losses and over-absorption of overhead in the nine months ended September 30, 2020 and the impact of foreign exchange fluctuations, government incentives and over-absorption of overhead in the nine months ended September 30, 2019, none of which are allocated to any individual segment for management’s internal reporting purposes. See Note 19—“Segment reporting” to our consolidated financial statements under Part I, Item 1—“Financial Statements” above.

Liquidity and Capital Resources

Overview

Information about our financial position as of December 31, 2019 and September 30, 2020 is presented below:

	As of December 31, 2019		As of September 30, 2020		Percentage Change Increase/(Decrease)
	(dollars in millions)						2020 vs. 2019
Cash and cash equivalents	$	467.1	$	803.4				72.0	%
Short-term borrowings		70.0		245.0				250.0
Long-term debt due within one year	33.5			33.5		0.1
Long-term debt other than the current portion		1,339.8		1,315.5				(1.8)
Genpact Limited total shareholders’ equity	$	1,689.2	$	1,777.2				5.2	%

Financial Condition

We have historically financed our operations and our expansion, including acquisitions, with cash from operations and borrowing facilities.

On February 6, 2020, our board of directors approved an approximately 15% increase in our quarterly cash dividend to $0.0975 per share, up from $0.085 per share in 2019, representing a planned annual dividend of $0.39 per common share, up from $0.34 per common share in 2019, payable to holders of our common shares. On March 18, 2020, June 26, 2020 and September 23, 2020, the Company paid a dividend of $0.0975 per share, amounting to $18,543, $18,595 and $18,637 in the aggregate, to shareholders of record as of March 9, 2020, June 11, 2020 and September 11, 2020, respectively.

As of September 30, 2020, $789.8 million of our $803.4 million in cash and cash equivalents was held by our foreign (non-Bermuda) subsidiaries. $11.6 million of this cash is held by foreign subsidiaries for which we expect to incur and have accrued a deferred tax liability on the repatriation of $5.6 million of retained earnings. $778.2 million of the cash and cash equivalents is held by foreign subsidiaries in jurisdictions where no tax is expected to be imposed upon repatriation of retained earnings or is being indefinitely reinvested.

The total authorization under our existing share repurchase program is $1,250.0 million, of which $200.5 million remained available as of September 30, 2020. Since our share repurchase program was initially authorized in 2015, we have repurchased 39,179,200 of our common shares at an average price of $26.8 per share, for an aggregate purchase price of approximately $1,049.5 million. This amount includes shares repurchased under our 2017 accelerated share repurchase program.

During the nine months ended September 30, 2020, we repurchased 1,781,978 of our common shares on the open market at a weighted average price of $41.3 per share for an aggregate cash amount of $73.6 million. During the nine months ended September 30, 2019, we repurchased 608,285 of our common shares on the open market at a weighted average price of $39.29 per share for an aggregate cash amount of $23.9 million. All repurchased shares have been retired. For additional information, see Note 17—“Capital stock” under Part I, Item 1—“Financial Statements” above.

We expect that in the future our cash from operations, cash reserves and debt capacity will be sufficient to finance our operations, our growth and expansion plans, dividend payments and additional share repurchases we may make under our share repurchase program. However, there is no assurance that the impacts we have experienced to date, and any future impact we may experience, from the COVID-19 pandemic will not have an adverse effect on our cash flows. In addition, we may raise additional funds through public or private debt or equity financings. Our working capital needs are primarily to finance our payroll and other administrative and information technology expenses in advance of the receipt of accounts receivable. Our primary capital requirements include opening new delivery centers, expanding existing operations to support our growth, financing acquisitions and enhancing capabilities, including building digital solutions.

Cash flows from operating, investing and financing activities, as reflected in our consolidated statements of cash flows, are summarized in the following table:

					Percentage Change
	Nine months ended September 30,				Increase/(Decrease)
	2019		2020		2020 vs. 2019
	(dollars in millions)
Net cash provided by (used for):
Operating activities	$	341.3	$	425.2		24.6	%
Investing activities		(86.0)		(55.9)		(35.0)	%
Financing activities	(154.2)		(1.6)			(99.0)	%
Net increase in cash and cash equivalents	$	101.1	$	367.7		263.7	%

Cash flows provided by operating activities. Net cash provided by operating activities was $425.2 million in the nine months ended September 30, 2020, compared to $341.3 million in the nine months ended September 30, 2019. This increase in cash inflow is primarily due to (i) a $10.6 million increase in net income in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019, (ii) a $44.7 million increase in non-cash expenses, primarily due to the write down of operating right-of-use assets and other assets as part of our COVID-19 related restructuring plan, higher write-downs of intangible assets and property, plant and equipment, higher depreciation and amortization, and increased unrealized losses on the revaluation of foreign currency assets/liabilities, partially offset by lower stock-based compensation expenses in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019, and (iii) a $28.6 million decrease in operating assets and liabilities driven by better days sales outstanding (DSO) and an increase in accounts payable in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019, partially offset by higher annual performance bonus payments and a tax deposit made in the nine months ended September 30, 2020 in connection with a 2013 Indian tax matter which is discussed under Part II, Item 1A—“Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2020—“Tax matters may have an adverse effect on our operations, effective tax rate and financial condition.”

Cash flows used for investing activities. Our net cash used for investing activities was $55.9 million in the nine months ended September 30, 2020, compared to $86.0 million in the nine months ended September 30, 2019. The reduction in cash used for investing activities is primarily due to payments for acquired/internally generated intangible assets and purchases of property, plant and equipment (net of sales proceeds), which were $23.8 million lower in the nine months ended September 30, 2020 than in the nine months ended September 30, 2019. Additionally, we made payments of $6.3 million related to an acquisition in the nine months ended September 30, 2019 for which there were no corresponding payments in the nine months ended September 30, 2020.

Cash flows used for financing activities. Our net cash used for financing activities was $1.6 million in the nine months ended September 30, 2020, compared to net cash used for financing activities of $154.2 million in the nine months ended September 30, 2019. We received proceeds from short-term borrowings (net of repayments) of $175.0 million in the nine months ended September 30, 2020 compared to the repayment of short-term borrowings (net of proceeds) of $50.0 million in the nine months ended September 30, 2019. For additional information, see Note 11 to our consolidated financial statements. Additionally, payments in connection with the net settlement of common shares under stock-based compensation plans were $33.2 million in the nine months ended September 30, 2020 compared to $3.2 million in the nine months ended September 30, 2019. Payments for share repurchases (including expenses related to repurchases) were $73.6 million in the nine months ended September 30, 2020, compared to $23.9 million in the nine months ended September 30, 2019. Dividend payments were $55.8 million in the nine months ended September 30, 2020 compared to $48.5 million in the nine months ended September 30, 2019. There were no payments related to earn-out or deferred consideration in the nine months ended September 30, 2020 compared to a payment of $12.8 million in the nine months ended September 30, 2019.

Financing Arrangements

As of December 31, 2019 and September 30, 2020, our outstanding term loan, net of debt amortization expense of $1.6 million and $1.3 million, respectively, was $627.4 million and $602.2 million, respectively. We also have fund-based and non-fund based credit facilities with banks, which are available for operational requirements in the form of overdrafts, letters of credit, guarantees and short-term loans. As of December 31, 2019 and September 30, 2020, the limits available under such facilities were $14.3 million and $14.2 million, respectively, of which $7.5 million and $6.2 million, respectively, was utilized, constituting non-funded drawdown. As of December 31, 2019 and September 30, 2020, a total of $72.1 million and $247.6 million, respectively, of our revolving credit facility was utilized, of which $70.0 million and $245.0 million, respectively, constituted funded drawdown and $2.1 million and $2.6 million, respectively, constituted non-funded drawdown.

In November 2019, we issued the 2019 Senior Notes, resulting in cash proceeds of approximately $398.3 million, net of an underwriting fee of $1.6 million and a discount of $0.1 million. In connection with the offering of the 2019 Senior Notes and the offering of $350 million aggregate principal amount of our 3.70% senior notes in March 2017 (the “2017 Senior Notes” and together with the 2019 Senior Notes, the “Senior Notes”), the Company incurred other debt issuance costs of $1.2 million related to the 2017 Senior Notes and $1.2 million related to the 2019 Senior Notes. The Senior Notes are fully guaranteed by the Company. The total debt issuance cost of $2.6 million and $2.9 million incurred in connection with the 2017 and 2019 Senior Notes offerings, respectively, are being amortized over the lives of the notes as an additional interest expense.

As of December 31, 2019 and September 30, 2020, the amount outstanding under our 2019 Senior Notes, net of debt amortization expense of $2.9 million and $2.4 million, respectively, was $397.1 million and $397.6 million, respectively. As of December 31, 2019 and September 30, 2020, the amount outstanding under our 2017 Senior Notes, net of debt amortization expense of $1.2 million and $0.8 million, respectively, was $348.8 million and $349.2 million, respectively. We pay interest on the 2017 Senior Notes semi-annually in arrears on April 1 and October 1 of each year and on the 2019 Senior Notes semi-annually in arrears on June 1 and December 1 of each year, ending on the maturity dates of April 1, 2022 and December 1, 2024, respectively.

For additional information, see Notes 11 and 12—“Short-term borrowings” and “Long-term debt” under Part I, Item 1—“Financial Statements” above.

Off-Balance Sheet Arrangements

Our off-balance sheet arrangements consist of foreign exchange contracts. For additional information, see Part I, Item 1A—“Risk Factors”—“Currency exchange rate fluctuations in various currencies in which we do business, especially the Indian rupee, the euro and the U.S. dollar, could have a material adverse effect on our business, results of operations and financial condition” in our Annual Report on Form 10-K for the year ended December 31, 2019, the section titled “Contractual Obligations” below, and Note 7 in Part I, Item 1—“Financial Statements” above.

Contractual Obligations

The following table sets forth our total future contractual obligations as of September 30, 2020:

	Total		Less than 1 year		1-3 years		3-5 years			After 5 years
	(dollars in millions)
Long-term debt	$	1,453.8	$	69.1	$	966.9	$	417.8	$	—
— Principal payments		1,349.0		33.5		917.9		397.6		—
— Interest payments*		104.8		35.6		49.0		20.2		—
Short-term borrowings		245.8		245.8	—		—			—
— Principal payments		245.0		245.0	—		—			—
— Interest payments**		0.8		0.8	—		—			—
Finance leases		51.4		17.6		26.3		7.5		—
— Principal payments		47.4		16.2		24.3		6.9			—
— Interest payments***		4.0		1.4		2.0		0.6			—
Operating leases		479.4		89.4		149.4		109.9			130.7
— Principal payments		370.4		65.2		116.9		86.0		102.3
— Interest payments***		109.0		24.2		32.5		23.9		28.4
Purchase obligations		32.8		28.2		4.6		—		—
Capital commitments net of advances		9.8		9.8	—		—			—
Earn-out consideration		21.1		6.5		14.6		—		—
— Reporting date fair value		18.2		5.0		13.2		—		—
— Interest		2.9		1.5		1.4		—		—
Other liabilities		104.8		60.3		44.4		0.1		—
Total contractual obligations	$	2,398.9	$	526.7	$	1,206.2	$	535.3		$	130.7

Our interest payments on long-term debt are calculated based on our current debt rating at a rate equal to LIBOR plus a margin of 1.375% per annum as of September 30, 2020, which excludes the impact of interest rate swaps. Interest payments on long-term debt also include interest on our senior notes due in 2022 and 2024 at a rate of 3.70% per annum and 3.375% per annum respectively, which is not based on LIBOR.

**	Our interest payments on short-term debt are calculated based on our current debt rating at a rate equal to LIBOR plus a margin of 1.375% per annum as of September 30, 2020 and our expectation for the repayment of such debt.

***	Our interest payments on finance leases and operating leases are based on the incremental borrowing rate prevailing in different jurisdictions.

Supplemental Guarantor Financial Information

As discussed in Note 12, “Long-term debt,” under Part I, Item 1—“Financial Statements” above, Genpact Luxembourg S.à r.l. (the “Issuer”), a wholly owned subsidiary of the Company (the “Guarantor”), issued the Senior Notes. As of September 30, 2020, the outstanding balance for the 2017 Senior Notes and the 2019 Senior Notes was $349.2 million and $397.6 million, respectively. Each issuance of Senior Notes was fully and unconditionally guaranteed by the Guarantor. The other subsidiaries of the Guarantor do not guarantee the Senior Notes (such subsidiaries are referred to as the “non-Guarantors”).

The Guarantor has fully and unconditionally guaranteed (i) that the payment of the principal, premium, if any, and interest on the Senior Notes shall be promptly paid in full when due, whether at stated maturity of the Senior Notes, by acceleration, redemption or otherwise, and that the payment of interest on the overdue principal and interest on the Senior Notes, if any, if lawful, and all other obligations of the Company to the holders of the Senior Notes or the trustee under the Senior Notes shall be promptly paid in full or performed, and (ii) in case of any extension of time of payment or renewal of any Senior Notes or any of such other obligations, that the same shall be promptly paid in full when due or performed in accordance with the terms of the extension or renewal, whether at stated maturity, by acceleration or otherwise. With respect to the Senior Notes, failing payment by the Issuer when due of any amount so guaranteed or any performance so guaranteed for whatever reason, the Guarantor shall be obligated to pay the same immediately. The Guarantor has agreed that this is a guarantee of payment of the Senior Notes and not a guarantee of collection.

The following tables present summarized financial information for the Issuer and the Guarantor on a combined basis after elimination of (i) intercompany transactions and balances among the Issuer and the Guarantor and (ii) equity in earnings from and investments in any subsidiary that is a non-Guarantor.

Summarized Statements of Income	Year ended December 31, 2019		Nine months ended September 30, 2020
	(dollars in millions)
Net revenues	$	59.7	$	44.6
Gross profit		59.7		44.6
Net income		44.0		28.0

Below is a summary of transactions with non-Guarantors included in the summarized statement of income above:

	Year ended December 31, 2019		Nine months ended September 30, 2020
	(dollars in millions)
Royalty income	$	59.7	$	44.6
Interest income (expense), net		54.7		40.3
Other cost, net		22.0		13.2

Summarized Balance Sheets	As of December 31, 2019		As of September 30, 2020
	(dollars in millions)
Assets
Current assets	$	1,062.9	$	1,237.7
Non-current assets		785.2		670.7

Liabilities and equity
Current liabilities	$	2,152.5	$	2,295.4
Non-current liabilities		1,333.6		1,330.6

Below is a summary of the balances with non-Guarantors included in the summarized balance sheets above:

	As of December 31, 2019		As of September 30, 2020
	(dollars in millions)
Assets
Current assets
Accounts receivable, net	$	84.8	$	81.3
Loans receivable		788.4		843.4
Others		175.8		251.3

Non-current assets
Investment in debentures/bonds	$	595.0	$	497.7
Loans receivable		100.0		100.0
Others		89.5		58.2

Liabilities
Current liabilities
Loans payable	$	1,976.1	$	2,107.0
Others		158.2		166.6

Non-Current liabilities
Loans payable	$	500.0	$	500.0

The Senior Notes and the related guarantees rank pari passu in right of payment with all senior and unsecured debt of the Issuer and the Guarantor and rank senior in right of payment to all of the Issuer’s and the Guarantor’s future subordinated debt. The Senior Notes are effectively subordinated to all of the Issuer’s and the Guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt. The Senior Notes are structurally subordinated to all of the existing and future debt and other liabilities of the Guarantor’s subsidiaries (other than the Issuer), including the liabilities of certain subsidiaries pursuant to our senior credit facility. The non-Guarantors are separate and distinct legal entities and have no obligation, contingent or otherwise, to pay any amounts due under the Senior Notes or to make the funds available to pay those amounts, whether by dividend, distribution, loan or other payment. Any right that the Issuer or the Guarantor have, to receive any assets of any of the non-Guarantors upon the insolvency, liquidation, reorganization, dissolution or other winding-up of any non-Guarantor, all of that non-Guarantor’s creditors (including trade creditors) would be entitled to payment in full out of that non-Guarantor’s assets before the holders of the Senior Notes would be entitled to any payment. Claims of holders of the Senior Notes are structurally subordinated to the liabilities of certain non-Guarantors pursuant to their liabilities under our senior credit facility.

Recent Accounting Pronouncements

Recently adopted accounting pronouncements

For a description of recently adopted accounting pronouncements, see Note 2(k)—“Recently issued accounting pronouncements” under Item 1—“Financial Statements” above and Part II, Item 7—“Management’s Discussion and Analysis of Financial Condition and Results of Operations”—“Critical Accounting Policies and Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2019.

Recently issued accounting pronouncements

For a description of recently issued accounting pronouncements, see Note 2(k)—“Recently issued accounting pronouncements” under Item 1—“Financial Statements” above and Part II, Item 7—“Management’s Discussion and Analysis of Financial Condition and Results of Operations”—“Critical Accounting Policies and Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2019.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We are exposed to interest rate risk arising from changes in interest rates on the floating rate indebtedness under our term loan and revolving credit facility and the Senior Notes. Borrowings under our term loan and revolving credit facility bear interest at floating rates based on LIBOR, but in no event less than the floor rate of 0.0% plus an applicable margin. The interest rate on our Senior Notes is subject to adjustment based on the ratings assigned to our debt by Moody’s and Investors Service, Inc. and Standard & Poor’s Rating Services, Inc. from time to time. A decline in such ratings could result in an increase of up to 2% in the rate of interest on the notes. Accordingly, fluctuations in market interest rates or decline in ratings may increase or decrease our interest expense which will, in turn, increase or decrease our net income and cash flow.

We manage a portion of our interest rate risk related to floating rate indebtedness by entering into interest rate swaps under which we receive floating rate payments based on the greater of LIBOR and the floor rate under our term loan and make payments based on a fixed rate. As of September 30, 2020, we were party to interest rate swaps covering a total notional amount of $495 million. Under these swap agreements, the rate that we pay to banks in exchange for LIBOR ranges between 0.38% and 2.65%.

For a discussion of our market risk associated with foreign currency risk, interest rate risk and credit risk, see Part II, Item 7A—“Quantitative and Qualitative Disclosures about Market Risk” in our Annual Report on Form 10-K for the year ended December 31, 2019.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are the Company’s controls and other procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 (“Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

As of the end of the period covered by this report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer along with the Company’s Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-15(b). Based upon that evaluation, the Company’s Chief Executive Officer along with the Company’s Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective in timely alerting them to material information relating to the Company (including its consolidated subsidiaries) required to be included in the Company’s periodic SEC filings.

Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarterly period ended September 30, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1.

Legal Proceedings

There are no legal proceedings pending against us that we believe are likely to have a material adverse effect on our business, results of operations and financial condition.

Item 1A.

Risk Factors

Except as described in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020, there have been no material changes with respect to the risk factors disclosed in our Annual Report on Form 10-K.

We have disclosed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019 and in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020 the risk factors that materially affect our business, financial condition or results of operations. You should carefully consider the risk factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2019 and in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020 and the other information that appears elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2019 and in this Quarterly Report on Form 10-Q. You should be aware that these risk factors and other information may not describe every risk facing our Company. Additional risks and uncertainties not currently known to us also may materially adversely affect our business, financial condition and/or results of operations.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities

None.

Use of Proceeds

None.

Purchase of Equity Securities by the Issuer and Affiliated Purchasers

Share repurchase activity during the three months ended September 30, 2020 was as follows:

Period	Total Number of Shares Purchased		Average Price Paid per Share ($)		Total Number of Shares Purchased as Part of Publicly Announced Plan or Program		Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan or Program ($)
July 1 – July 31, 2020		—		—		—		229,042,368
August 1-August 31, 2020		—		—		—		229,042,368
September 1 - September 30, 2020		739,790		38.59		739,790		200,490,566

Since February 2017, our Board of Directors (the “Board”) has authorized repurchases of up to $1.25 billion under our existing share repurchase program. This repurchase program does not obligate us to acquire any specific number of shares and does not specify an expiration date. All shares repurchased under the plan have been retired. For additional information, see Notes 17 and 28—“Capital Stock” and “Subsequent Events” under Part I, Item 1— “Financial Statements” above.

Item 6.

Exhibits

Exhibit Number		Description

3.1		Memorandum of Association of the Registrant (incorporated by reference to Exhibit 3.1 to Amendment No. 2 of the Registrant’s Registration Statement on Form S-1 (File No. 333-142875) filed with the SEC on July 16, 2007).

3.2		Bye-laws of the Registrant (incorporated by reference to Exhibit 3.3 to Amendment No. 4 of the Registrant’s Registration Statement on Form S-1 (File No. 333-142875) filed with the SEC on August 1, 2007).

22.1		List of Issuers and Guarantor Subsidiaries (incorporated by reference to Exhibit 22.1 to the Registrant’s Quarterly Report on Form 10-Q (File No. 001-33626) filed with the SEC on May 11, 2020).

31.1*		Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*		Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*		Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS*		Inline XBRL Instance Document — the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH*		Inline XBRL Taxonomy Extension Schema Document

101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104*		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*	Filed or furnished with this Quarterly Report on Form 10-Q.

†	Indicates a management contract or compensatory plan, contract or arrangement in which any director or executive officer participates.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 9, 2020

GENPACT LIMITED

By:		/s/ N.V. TYAGARAJAN
		N.V. Tyagarajan
		Chief Executive Officer

By:		/s/ EDWARD J. FITZPATRICK
		Edward J. Fitzpatrick
		Chief Financial Officer

g-ex311_6.htm

Exhibit 31.1

CHIEF EXECUTIVE OFFICER CERTIFICATION

I, N.V. Tyagarajan, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Genpact Limited for the period ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 9, 2020

/s/ N.V. Tyagarajan

N.V. Tyagarajan

Chief Executive Officer

g-ex312_8.htm

Exhibit 31.2

CHIEF FINANCIAL OFFICER CERTIFICATION

I, Edward J. Fitzpatrick, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Genpact Limited for the period ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 9, 2020

/s/ Edward J. Fitzpatrick

Edward J. Fitzpatrick

Chief Financial Officer

g-ex321_9.htm

Exhibit 32.1

Certification of the Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Genpact Limited (the “Company”) on Form 10-Q for the period ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, N.V. Tyagarajan, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 9, 2020

/s/ N.V. Tyagarajan

N.V. Tyagarajan

Chief Executive Officer

g-ex322_7.htm

Exhibit 32.2

Certification of the Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Genpact Limited (the “Company”) on Form 10-Q for the period ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Edward J. Fitzpatrick, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 9, 2020

/s/ Edward J. Fitzpatrick

Edward J. Fitzpatrick

Chief Financial Officer